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Abstract 
 
Methane producing archaea have a vital role in the global carbon cycle by 
facilitating the conversion of organic carbon into CO2 and methane. Species of 
Methanosarcina are unique among methanogens due to a versatile metabolism 
that allows the use of a wide range of substrates through four overlapping 
methanogenic pathways. Two of the pathways require H2 as a substrate, while 
the others can use H2 as an electron carrier via a hydrogen cycling mechanism, 
which was previously demonstrated for Methanosarcina barkeri. Both uses of H2 
require the activity of three different hydrogenase enzymes, however, M. barkeri 
can also utilize an electron transport system that is independent of hydrogenase 
activity. In Chapter 2, the interconnected nature of H2-dependent and H2-
independent metabolic pathways was investigated in a series of M. barkeri 
hydrogenase deletion mutants. Phenotypic analysis of these mutants, including 
characterization of growth, methanogenesis, and gene regulation, allowed 
detection of an alternative ferredoxin-dependent electron transport system that 
does not require the production or consumption of H2. Additionally, we found that 
H2-dependent inhibition of the oxidative branch of methanogenesis required 
active hydrogenases, and that M. barkeri was potentially able to regulate gene 
expression based on the redox state of coenzyme F420. In Chapter 3, I explored 
the regulation of hydrogenases in Methanosarcina acetivorans, a species that is 
incapable of metabolizing H2, yet encodes hydrogenases with high similarity to 
the active enzymes found in M. barkeri. Despite the lack of hydrogenase activity 
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in its native host, I found that the Vht hydrogenase from M. acetivorans was fully 
active when expressed in M. barkeri. Further assessment of Vht from M. 
acetivorans revealed that transcript levels were diminished when compared to M. 
barkeri, and that the hydrogenase protein was not detectable when expressed 
from the native promoter. In addition to Vht regulation at the transcriptional and 
translational levels, I found that M. acetivorans has a mechanism of post-
translational control that disallows maturation of the hydrogenase into a fully 
active enzyme. Finally, in Chapter 4 I summarize the significant findings of this 
research, and outline several projects for continued investigation of energy 
conservation and gene regulation in Methanosarcina. 
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Chapter 1: Introduction 
 
 Methanogenic archaea play a critical role in the global carbon cycle, by 
virtue of their ability to facilitate the terminal process of organic matter 
decomposition into methane and carbon dioxide (CO2) in anaerobic 
environments. It is estimated that approximately 2% of CO2 that is fixed into 
biomass each year by photosynthetic organisms will eventually be converted into 
methane, a process that produces around 1 billion tons of methane annually (103, 
104). Sixty percent of this methane is oxidized to CO2 by methane-consuming 
organisms and 40% is released into the atmosphere (103, 104). As a result, 
biological methane production accounts for approximately 72-74% of methane 
emissions (Figure 1.1) (24, 69). Atmospheric methane concentrations have more 
than doubled since the onset of the industrial revolution (late 1700s), and levels 
continue to rise (24, 83). Evidence from carbon isotope data suggests that this 
increase can be primarily attributed to biologically produced methane (83). Rising 
atmospheric methane concentrations is of particular concern, as methane has a 
global warming potential that is 28-34 times higher than CO2 over a 100-year 
period (24). In order to mitigate rising methane levels, a more in depth 
understanding of the metabolism and physiology of the organisms driving this 
increase must be obtained. 
 Methanogens are nearly ubiquitous in anaerobic environments, and have 
been found to thrive in environments with a wide range of temperature, salinity, 
and pH. This includes marine and freshwater sediments, wetlands, geothermal 
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systems, permafrost soils, anaerobic sewage digesters, landfills, and the 
intestinal tracts of ruminants, humans, and termites (69). Wetlands are by far the 
largest natural source of biological methane production; however, human-
influenced production of methane by methanogens remains the largest overall 
source (Figure 1.1). This includes emissions related to agriculture [ruminant-
associated methanogenesis (18% of total methane emissions) and rice paddy 
soils (5%)] and landfill and waste decomposition (10%) (24). On the one hand, 
the level of human-influenced methane emissions is concerning; but on the other, 
biologically produced methane is potentially a valuable resource for energy 
production. 
 Due to their prolific production of methane and the diverse environments 
in which they thrive, methanogens are ideally suited for the production of biogas, 
a renewable alternative to fossil natural gas that is composed primarily of 
methane. Systems have already been established for the conversion of organic 
matter into methane by methanogens in biogas reactors (35). More than 2,000 
biogas production facilities are already in use in the United States, and it is 
estimated that full implementation of all potential sites could provide enough 
energy to power more than 3.5 million homes (106). Improving the rate and 
efficiency of this process could increase this number even further (35). 
Additionally, in order to be fed into existing gas distribution networks, biogas has 
to be purified and methane-enriched. Therefore, a careful consideration of the 
physiology of methanogens will enable both an enhancement of methane 
production in biogas reactors, and a reduction in overall methane emissions. 
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Figure 1.1. Sources of atmospheric methane. The proportion of atmospheric 
methane emissions caused by anthropogenic activities (red), produced by 
biogenic processes (blue), and the overlap between the two categories (purple) 
is shown. Percentages of each methane source were determined from 
atmospheric observation-based calculations reported by Dean, et al (24). The 
category “Other Natural Sources” is primarily composed of biologically produced 
methane (8% of total) in freshwater and marine sediments, and geologically 
produced methane (3% of total). 
 
Diversity of methanogens 
 Methanogenic archaea belong to a large and phylogenetically diverse 
group with varying metabolic capabilities and requirements. Until recently, 
methanogens were thought to solely belong to the phylum Euryarchaeota, and 
were assigned to 8 different orders based on 16S rRNA sequence similarity. This 
includes: Methanobacteriales, Methanococcales, Methanomicrobiales, 
Methanosarcinales, Methanopyrales, Methanocellales, Methanomassiliicoccales, 
and Methanonatronarchaeales (54, 69, 89, 96). Recently, three novel taxa of 
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methanogenic archaea have been proposed based on metagenomic data of 
uncultured organisms, including Candidatus ‘Methanofastidiosa’, and members 
of the Bathyarchaeota and Verstraetearchaeota phyla (36, 84, 108). The first 
represents a distinct class within Euryarchaeota (84); however, the latter two are 
representatives of phyla separate from Euryarchaeota (36, 108). The discovery 
of methanogen lineages outside of Euryarchaeota has led to the hypothesis that 
the last archaeal common ancestor (LACA) was potentially a methanogen. This 
idea is supported by the highly divergent sequences of genes required for 
methanogenesis in Bathyarchaeota genomes, which is consistent with vertical 
inheritance instead of horizontal gene transfer (14). However, establishing the 
methanogenic nature of LACA requires a more confident rooting of the archaeal 
phylogenetic tree and a more extensive search for methanogenesis related 
genes in undiscovered organisms throughout all archaeal phyla (71, 98).  
 In addition to their genetic diversity, each order of methanogenic archaea 
has unique characteristics, such as their metabolic capabilities or the 
environments from which they can be isolated. Members of the 
Methanobacteriales order have been isolated from a wide variety of 
environments, including marine and freshwater sediments, permafrost, hot 
springs, alkaline lakes, and the gastrointestinal tract of various animals. As such, 
the requirements for growth in this order are quite varied. Most species are 
limited to utilizing CO2 and H2 for methanogenesis, but some members of this 
order are capable of using formate, CO, or secondary alcohols (i.e. 2-propanol, 
2-butanol) as electron donors for reduction of CO2 to methane (71). While some 
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strains are autotrophs, many are heterotrophs that require exogenous acetate, 
amino acids, or vitamins for growth. Lastly, one genus, Methanosphaera, cannot 
reduce CO2 to methane and is limited to utilizing methanol with H2 for 
methanogenesis (42, 77). 
 All members of the Methanococcales order were isolated from marine 
environments and are capable of utilizing CO2 and H2 as substrates for 
methanogenesis. Some species are also able to use formate as an electron 
donor. Many members of this order are thermophilic or hyperthermophilic, and 
were isolated from deep-sea hydrothermal vents or other marine sediments (71). 
As a corollary, Methanococcales species have some of the fastest growth rates 
of all methanogens, with a rate as fast as 2.4 h-1 found in Methanocaldococcus 
jannaschii (58, 76). 
 With a few exceptions, most members of the Methanomicrobiales order 
are mesophilic and require near-neutral pH conditions for ideal growth. Like 
members of Methanococcales, all Methanomicrobiales species can reduce CO2 
to methane with electrons derived from H2, and most can also use formate as an 
electron source. Additionally, some species are able to oxidize secondary 
alcohols for the reduction of CO2. Many species also require supplementation 
with acetate or other organic substrates, such as yeast extract or rumen fluid (71). 
This order also includes two organisms, Methanofollis ethanolicus and 
Methanogenium organophilum, with the unique ability to utilize the primary 
alcohol, ethanol, for methanogenesis (55, 116). 
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 The orders Methanopyrales, Methanomassiliicoccales, and 
Methanocellales are sparsely populated at present, with the first two consisting of 
a single isolated species and the last consisting of a single genus with three 
species (71). Aside from that commonality, organisms from each of these orders 
are drastically different. Strains of Methanopyrus kandleri from the 
Methanopyrales order reduce CO2 to methane with electrons from H2, were 
isolated from hydrothermal marine sediments, and are the only methanogens 
known to be capable of methanogenesis above 100 °C (66, 101). The 
Methanomassiliicoccales order consists of one isolated species, 
Methanomassiliicoccus luminyensis, and at least three other proposed species 
based on genome sequences from enriched cultures (12, 13, 33, 54). M. 
luminyensis is limited to methanogenesis via reduction of methanol with H2, and 
was isolated from human fecal matter (33). Lastly, all three species of the 
Methanocellales order were isolated from the soil of rice paddies and utilize CO2 
and H2 for methanogenesis. Two of the species can also use formate as an 
electron donor, and all three require supplementation with acetate for growth (71). 
 Methanonatronarchaeales is the most recently recognized order of 
methanogens, and consists of organisms isolated from sediments of hypersaline 
chloride-sulfate and soda lakes (96). Most organisms from this order are 
thermophiles and alkaliphiles, with optimal growth conditions of 50 °C and a pH 
of 9.5 - 9.8. Additionally, all are halophiles with an optimum Na+ concentration of 
4.0 M. In a mechanism that is unique among halophilic methanogens, this order 
overcomes osmotic stress by maintaining high intracellular potassium 
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concentrations. Lastly, all members of this order, like those of the 
Methanomassiliicoccales order, generate methane by reducing methyl 
compounds with electrons derived from H2. However, unlike other taxa that are 
limited to reducing methyl compounds with H2, the Methanonatronarchaeales are 
also able to utilize formate as an electron source (96). 
 Members of the final order, Methanosarcinales, are widely distributed and 
can be found in environments ranging from marine and freshwater sediments to 
gastrointestinal tracts and anaerobic sewage digesters. Additionally, species 
from this order have the widest substrate range of all methanogens, and can 
utilize CO2 + H2, CO, acetate, or methyl compounds (e.g. methanol, 
methylamines, methyl sulfides) for methanogenesis (71, 103). In addition to 
these substrates, a single isolate, Methermicoccus shengliensis, is able to use 
methoxylated aromatic compounds, as can be found in immature coal deposits, 
for methanogenesis via an enigmatic mechanism (73). Despite this broad 
substrate range, no member of the Methanosarcinales order is able to utilize 
formate as an electron donor, which is in stark contrast to the majority of other 
methanogen orders. A final difference between members of Methanosarcinales 
and all other orders of methanogenic archaea is that they alone contain 
cytochromes and the lipid-soluble electron carrier methanophenazine, the 
significance of which will be discussed in the following sections (103). 
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Metabolic pathways for methanogenesis 
  A common characteristic of all known methanogens is that they are 
obligate methane producers, meaning their only system for energy conservation 
comes from the reduction of a small number of substrates to methane. As 
described in the previous section, nearly all methanogens are capable of 
reducing CO2 to methane with electrons derived from the oxidation of H2, formate, 
or secondary alcohols via the CO2 reduction pathway (Figure 1.2) (69, 71). In 
addition to this pathway, members of the Methanosarcinales order can utilize 
three other methanogenic pathways in order to metabolize acetate (aceticlastic 
pathway; Figure 1.3) or methyl compounds (methyl reduction pathway and 
methylotrophic pathway; Figures 1.4 & 1.5) (46, 69). The two pathways involving 
methyl compounds differ by the source of electrons for reduction of the methyl 
group to methane. H2 oxidation provides electrons in the methyl reduction 
pathway, but in the methylotrophic pathway methyl compounds serve as both the 
oxidant and reductant. Whereas only species in the Methanosarcinales order are 
able to utilize the aceticlastic and methylotrophic pathways, three additional 
classes of methanogens can use the methyl reduction pathway. This includes 
organisms from the Methanosphaera genus in the Methanobacteriales order, and 
organisms from the Methanomassiliicoccales and Methanonatronarchaeales 
orders (71, 96). Based on metagenomic data, Candidatus ‘Methanofastidiosa’ 
may also rely on this pathway to reduce methylated thiols (84). 
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The CO2 reduction pathway 
 The CO2 reduction pathway is characterized by  the stepwise reduction of 
CO2 to methane with electrons derived from the oxidation of H2, which is 
mediated by a group of enzymes known as hydrogenases (Figure 1.2). The 
overall standard free energy change (ΔG°’) for this process is -131 kJ per mole. 
However, when accounting for the low partial pressure of H2 in natural 
environments, this value drops to between -17 and -40 kJ per mole. Therefore, 
less than one mole of ATP can be synthesized from ADP and Pi (ΔG°’= +32 kJ 
per mole) for each mole of methane that is produced (103). Many methanogens 
can also use electrons from formate oxidation by formate dehydrogenases (Fdh) 
for the reduction of CO2 to methane (22, 68, 90). However, as mentioned above, 
species from the Methanosarcinales order are not able to use formate as a 
substrate, and are thus restricted to utilizing H2 as a reductant for this type of 
methanogenesis. The initial reduction of CO2 to a formyl group attached to the C1 
carrier molecule methanofuran (MF) requires energy input in the form of reduced 
ferredoxin (Fdred), a low redox potential electron carrier. Methanogens have 
several strategies for generating Fdred, which will be discussed in the “Energy 
conservation mechanisms of methanogens” section below. In one example, 
some species of Methanosarcina generate Fdred by the membrane-bound, 
proton-translocating Ech hydrogenase, wherein the energetically unfavorable 
reduction of Fd by H2 oxidation is made possible by coupling the reaction to 
proton translocation from the outside to the inside of the cell (50, 75, 103). The 
formyl group is subsequently transferred from MF to another C1 carrier molecule,  
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Figure 1.2. CO2 reduction pathway of 
Methanosarcina. In this pathway, CO2 is 
reduced to CH4 in a stepwise manner. For each 
reduction step, electrons are derived from the 
oxidation of H2 by hydrogenases Ech, Frh, and 
Vht, as indicated. Electron carriers include 
ferredoxin (Fd), cofactor F420 (F420), and 
methanophenazine (MP). In the final 
methanogenic step, the coenzyme M (CoM)-
bound methyl group is reduced by coenzyme B 
(CoB), thereby forming CH4 and a disulfide of the 
two coenzymes (CoM-CoB). Reduced forms of 
CoM and CoB are regenerated from the disulfide 
by the heterodisulfide reductase (Hdr). 
Abbreviations used include MF for 
methanofuran, H4SPT for 
tetrahydrosarcinapterin, and 
red/ox subscripts to indicate 
reduced or oxidized states of 
electron carriers. 
 
tetrahydrosarcinapterin (H4SPT), and then converted to methenyl-H4SPT via a 
condensation reaction catalyzed by the cyclohydrolase enzyme, Mch (111). Two 
reduction steps follow (methenyl-H4SPT to methylene-H4SPT and methylene-
H4SPT to methyl-H4SPT), in which the required reduced coenzyme F420 
(F420red) is supplied by the Frh hydrogenase (62). After the exergonic transfer of 
the methyl group to coenzyme M (CoM) by the membrane-bound methyl-
H4SPT:CoM methyltransferase enzyme (Mtr) (44), the final reduction step occurs 
with coenzyme B (CoB), resulting in production of methane and a disulfide of 
CoM and CoB (CoM-CoB) (102, 111). Continued methanogenesis relies on 
regeneration of CoM and CoB by reducing CoM-CoB, and is facilitated by the 
heterodisulfide reductase (Hdr) enzyme. In Methanosarcina species, the 
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membrane-bound and cytochrome-containing HdrED catalyzes this reaction with 
electrons ultimately derived from H2 by way of the Vht hydrogenase and the 
membrane soluble electron carrier, methanophenazine (MP) (31). Thus, the 
reduction of CO2 to methane with electrons derived from H2 in Methanosarcina 
species requires three different types of hydrogenases. 
 
The aceticlastic pathway 
 It has been estimated that most biologically produced methane (ca. 2/3 
globally) comes from the methyl group of acetate by the processes of syntrophic 
acetate oxidation or aceticlastic methanogenesis (37, 38, 48). The former 
process is facilitated by interaction between an acetate-oxidizing bacteria and a 
H2-consuming, CO2- reducing methanogen. Oxidation of acetate to CO2 and H2 
is very energetically unfavorable, unless the end products are rapidly consumed 
by the methanogen (48). Only two genera from the Methanosarcinales order, 
Methanosarcina and Methanothrix, are able to perform the latter process, the 
direct utilization of acetate for methanogenesis. Production of methane from 
acetate during aceticlastic methanogenesis results in the lowest free energy 
availability of all substrates (ΔG°’= -36 kJ per mole) (30, 93, 115). During this 
process, one molecule of acetate is converted into one molecule of methane and 
one molecule of CO2. In the first step of this pathway, acetate is converted into 
acetyl-CoA in an ATP-dependent manner. The acetyl group is then split into an 
enzyme-bound carbonyl group and a methyl group by the acetyl-CoA 
decarbonylase/synthase (ACDS) enzyme complex (Figure 1.3) (43, 45). 
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Oxidation of the carbonyl to CO2 results in Fdred, which is used to reduce the 
methyl group to methane. After the initial cleavage of acetate, the methyl group is 
transferred to H4SPT, and the same reduction process involving CoM, CoB, Hdr, 
and MPred, as described above for the CO2 reduction pathway occurs (115). In 
Methanosarcina species, there are two different mechanisms for transferring 
electrons from the oxidative to the reductive portions of the pathway, as will be 
discussed in Chapter 2. Species with active hydrogenases, such as 
Methanosarcina barkeri, use a hydrogen cycling mechanism, whereas species 
that are hydrogenase-deficient, such as Methanosarcina acetivorans, have a H2-
independent electron transport system. In the H2 cycling mechanism, the Ech 
hydrogenase proceeds in the opposite direction described for the CO2 reduction 
pathway by oxidizing Fdred, which generates H2 and allows for proton 
translocation across the membrane, thereby contributing to the proton motive 
force (113). H2 then diffuses across the membrane and is oxidized by the Vht 
hydrogenase, where the electrons are used to reduce CoM-CoB via MPred and 
Hdr (Figure 1.3) (63, 74, 75). Species that utilize the H2-independent electron 
transport system do not have Ech, and instead use a Rnf complex to catalyze the 
transfer electrons from Fdred to MP (67, 112). Like Ech, Rnf translocates ions 
across the membrane due to the exergonic nature of MP reduction with Fdred 
(ΔG°’= -68 kJ per mole). However, whereas Ech translocates protons, Rnf 
conserves energy by translocating sodium ions (92). Despite these differences, 
M. barkeri and M. acetivorans have similar growth rates and yields on acetate, 
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indicating both electron transport systems conserve approximately equivalent 
amounts of energy (97). 
 
 
Figure 1.3. The aceticlastic pathway of methanogenesis for M. barkeri. 
Acetate is split into an enzyme-bound carbonyl ([CO]) and a methyl group, which 
gets transferred to the C1 carrier tetrahydrosarcinapterin (H4SPT). Oxidation of 
[CO] to CO2 produces reduced ferredoxin (Fdred), which is oxidized by the Ech 
hydrogenase, thereby generating H2 inside the cell. H2 diffuses across the cell 
membrane to the Vht hydrogenase active site, where it is oxidized and electrons 
are used to reduce methanophenazine (MPred). Reduction of the methyl group 
bound to coenzyme M (CoM) by coenzyme B (CoB) produces CH4 and a 
disulfide of CoM and CoB (CoM-CoB), which is regenerated by reduction with 
electrons from MPred via the heterodisulfide reductase enzyme (Hdr). Portions of 
the methanogenic pathway that are not required for aceticlastic methanogenesis, 
including the use of the Frh hydrogenase, are shown in light gray. Abbreviations 
used include MF for methanofuran, F420 for coenzyme F420, and red/ox 
subscripts to indicate reduced or oxidized states of electron carriers. 
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The methylotrophic pathway 
 Only members of the Methanosarcinales order, excluding Methanosaeta 
species, are capable of utilizing the methylotrophic pathway for methanogenesis 
(71). In this pathway, methyl compounds such as methanol, methylamines, and 
methyl sulfides serve as the source of carbon and energy. Compared to the CO2 
reduction and aceticlastic pathways, substantially more energy is available from 
methylotrophic methanogenesis (ΔG°’= -106 and -77 kJ per mole methane from 
methanol and methylamine, respectively) (30, 32). To serve as both the 
reductant and oxidant, methyl compounds are disproportionated such that the 
oxidation of one methyl group to CO2 provides the reducing equivalents needed 
for the reduction of three methyl groups to methane (102). At the outset, methyl 
groups are transferred to CoM by the sequential action of two methyltransferases 
(MT1 and MT2). Methanosarcina species encode multiple MT1 and MT2 
isozymes that are specific for different methyl-group containing substrates (15). 
From the methyl-CoM level, methyl groups are either oxidized to CO2 in a 
reversal of the CO2 reduction pathway, or reduced to methane by CoB in a 
manner that is identical in all four methanogenic pathways (Figure 1.4). The 
oxidative portion of the pathway generates F420red and Fdred, which is used in the 
reduction portion of the pathway (60). As with aceticlastic methanogenesis, two 
different mechanisms are used to transfer electrons from the oxidative to the 
reductive portions of the pathway, depending on hydrogenase availability (46, 47). 
In hydrogenase-proficient species, such as M. barkeri, a hydrogen cycling 
mechanism is utilized in which F420red and Fdred are oxidized by the Frh and Ech 
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Figure 1.4. The methylotrophic pathway of methanogenesis for M. barkeri. 
In this pathway, methyl compounds undergo disproportionation, wherein the 
oxidation of one methyl group to CO2 provides the reducing equivalents for the 
reduction of three additional methyl groups to CH4. In the oxidation portion of the 
pathway, methyl groups are first transferred to coenzyme M (CoM) and then 
transferred to tetrahydrosarcinapterin (H4SPT). The methyl group is oxidized in 
two successive steps, first to methylene-H4SPT and then to methenyl-H4SPT, 
which produces two reducing equivalents in the form of reduced coenzyme F420 
(F420red). The third reducing equivalent comes from the oxidation of formyl-
methanofuran (MF), which produces CO2 and reduced ferredoxin (Fdred). In the 
reduction portion of the pathway, methyl-CoM is reduced by coenzyme B (CoB), 
which forms CH4 and a disulfide of CoM and CoB (CoM-CoB). Regeneration of 
CoM and CoB requires reduction of the disulfide by the heterodisulfide reductase 
enzyme (Hdr) with electrons from reduced methanophenazine (MPred). The 
transfer of electrons from the oxidative to reductive portions of the pathway 
occurs via a hydrogen cycling mechanism in M. barkeri. In this mechanism, 
F420red and Fdred are oxidized by the Frh and Ech hydrogenases, respectively, 
which forms H2 on the inside of the cell. The H2 then diffuses across the 
membrane to the Vht hydrogenase active site on the outside of the cell, where it 
is oxidized and electrons are passed to MP, thereby completing the cycle. 
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hydrogenases, respectively, thereby generating H2 inside the cell. The H2 then 
diffuses across the cell membrane to the Vht hydrogenase active site, where it is 
oxidized and electrons are passed to MP to be used for the reduction of CoM-
CoB (Figure 1.4) (63). In hydrogenase-deficient species, such as M. acetivorans, 
two different membrane-bound enzyme complexes are utilized. The first, Rnf, 
transfers electrons from Fdred to MP and functions as described for the 
aceticlastic pathway (67, 92, 112). The second enzyme complex, F420 
dehydrogenase (Fpo), catalyzes the transfer of electrons from F420red to MP (31). 
Fpo contributes to the proton motive force by translocating additional protons 
across the cell membrane (6, 53). It should be noted that M. barkeri is capable of 
both H2-dependent and H2-independent electron transport; however, 
experimentally-derived mutant strains that lack Frh and are therefore limited to 
utilizing Fpo for F420:MP oxidoreductase activity grow far slower than the 
wildtype strain (62). 
 
The methyl reduction pathway 
 Outside of the Methanosarcinales order, only three other classes of 
methanogens are able to utilize the methyl reduction pathway, which includes a 
single genus (Methanosphaera) of the Methanobacteriales order, the 
Methanomassiliicoccales order, and the Methanonatronarchaeales order. 
Additionally, Candidatus ‘Methanofastidiosa’ likely relies on this pathway for the 
reduction of methylated thiols, based on metagenomic data (84). In this pathway, 
methyl compounds are reduced to methane with electrons derived from H2 (11).  
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Figure 1.5. The methyl reductive 
methanogenic pathway in 
Methanosarcina. In this pathway, 
methyl groups are transferred to 
coenzyme M (CoM), and then reduced to 
CH4 by coenzyme B (CoB), which forms a 
disulfide of CoM and CoB (CoM-CoB). 
Regeneration of CoM and CoB by 
the reduction of CoM-CoB occurs 
at the heterodisulfide reductase 
enzyme (Hdr) with electrons from 
reduced methanophenazine 
(MPred). The Vht hydrogenase 
generates MPred with electrons 
derived from the oxidation of H2. 
Portions of the core 
methanogenic pathway 
that are not used by 
the methyl reduction 
pathway, including 
the Ech and Frh hydrogenases, are shown in 
light gray. Abbreviations include: MF, methanofuran; H4SPT, 
tetrahydrosarcinapterin; Fdred/Fdox, reduced and oxidized ferredoxin; 
F420red/F420ox, reduced and oxidized coenzyme F420. 
 
The amount of energy made available by this reaction is fairly high under 
standard conditions (ΔG°’= -113 kJ per mole), but is likely to be much lower in 
the H2-limiting conditions found in natural environments (103). In Methanosarcina 
species, the transfer of a methyl group to CoM, reduction to methane by CoB, 
reduction of CoM-CoB by Hdr, and H2:MP oxidoreductase activity of Vht all occur 
as described for the CO2 reduction, aceticlastic, and methylotrophic pathways 
(Figure 1.5). The model for the methyl reduction pathway predicts that the Ech 
and Frh hydrogenases should not be required for methanogenesis, which has 
been confirmed by mutational studies (62, 75). However, despite the ability to 
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produce methane, the strain lacking Ech was unable to grow via this pathway 
unless supplemented with acetate or pyruvate, indicating Ech has a biosynthetic 
role during growth with methyl compounds and H2. It is presumed that Ech is 
required for the H2-dependent production of Fdred that is required for acetyl-CoA 
and pyruvate synthesis (75). 
 
Energy conservation mechanisms of methanogens 
 Methanogens, like all living organisms, require energy derived from 
metabolic processes to be conserved for growth and cellular maintenance. 
However, they are unable to generate ATP via substrate level phosphorylation, 
and are instead limited to ion-gradient-dependent ATP generation via an ATP 
synthase (11, 32). Due to the limited amount of energy available from 
methanogenic substrates, very few steps in methanogenic pathways are 
sufficiently exergonic to translocate ions across the cell membrane (103). 
Additionally, there is a significant divide in energy conservation systems such 
that methanogens can be grouped into one of two categories: i) those that 
contain cytochromes, and ii) those that do not contain cytochromes (103). Most 
methanogens belong to the second group, and the presence of cytochromes is 
both ubiquitous and exclusive to the Methanosarcinales order. While the 
utilization of cytochromes introduces a unique energy conservation system, these 
two categories of methanogens also share mechanisms that are common to all 
methanogen classes (32, 103).  
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Establishing a primary Na+ ion gradient with Mtr 
 A characteristic feature of methanogens with and without cytochromes is 
the dependence on sodium ions (Na+) for growth and methanogenesis (85, 86, 
103). This requirement is due to an energy conservation mechanism that is 
shared by both types, which is catalyzed by the methyl-H4SPT:CoM 
methyltransferase (Mtr) (7, 44, 107). The transfer of a methyl group from H4SPT 
to CoM is exergonic (ΔG°’= -29 kJ per mole), thereby allowing for the 
translocation of approximately 2 Na+ across the membrane and contributing to 
ion motive force (93). All methanogens that are able to utilize the CO2 reduction 
or aceticlastic pathways (Figures 1.2 & 1.3) have this mechanism for energy 
conservation. During methylotrophic methanogenesis, methyl transfer occurs in 
the opposite direction (Figure 1.4), such that consumption of the Na+ ion motive 
force is required to facilitate this endergonic reaction (32, 80). 
 
Electron bifurcation and methanogenesis as a cycle 
 All methanogenic pathways generate a CoM-CoB disulfide in the terminal 
methane-generating step. Reduction of CoM-CoB is another energy conserving 
reaction common to all methanogens; however, different mechanisms for this 
process have evolved in methanogens with cytochromes versus those without 
cytochromes. Those without cytochromes utilize an energy conservation 
mechanism that was discovered relatively recently: flavin-based electron 
bifurcation (FBEB) (20, 103). With this mechanism, the endergonic reduction of 
ferredoxin (Fd; E°’≈ -500 mV) by H2 oxidation (E°’= -414 mV) is coupled to the 
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exergonic reduction of CoM-CoB (E°’= -140 mV) by H2 oxidation. Thus, the 
overall reaction (Fdox + CoM-CoB + 2H2 o Fdred + CoM + CoB + 2H+) is 
energetically favorable (ΔG°’= -50 kJ per mole) (20). The FBEB mechanism is 
facilitated by the MvhADG:HdrABC enzyme complex, wherein MvhADG 
catalyzes H2 oxidation and HdrABC catalyzes CoM-CoB and Fd reduction (20, 59, 
99). The HdrABC enzyme is a class of heterodisulfide reductase that is distinct 
from the HdrED enzyme found in Methanosarcina species, and is neither 
cytochrome-containing nor membrane-bound (19, 49). Some cytochrome-
deficient methanogens are also able to couple Fd and CoM-CoB reduction to 
formate oxidation. In these organisms, HdrABC also forms a complex with a 
formate dehydrogenase (Fdh) (22, 79). The Fdred produced by FBEB is required 
for the initial step in the CO2 reduction pathway, the reduction of CO2 to formyl-
MF (Figure 1.2), which has a reduction potential of E°’≈ -500 mV (20). Thus, in 
cytochrome-deficient methanogens the first and final steps of the methanogenic 
pathway are energetically linked via FBEB, leaving the Na+-dependent Mtr 
reaction as the only mechanism for generating an ion gradient for ATP synthesis.  
 Coupling of the first and last methanogenic steps by FBEB confirms the 
cyclical nature of methanogenesis, as proposed 30 years ago by Rouvière and 
Wolfe (88). Recent elucidation of anaplerotic mechanisms required to replenish 
cycle intermediates that are withdrawn for biosynthesis further support 
methanogenesis as a cycle (68). The cyclization of methanogenesis by way of 
FBEB is now referred to as the Wolfe cycle to honor the influence of Ralph S. 
Wolfe on the field of methanogenic biochemistry (105). 
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 Methanogens with cytochromes also have a putative electron bifurcating 
system, which is enabled by the heterodisulfide reductase homolog HdrA2B2C2 
(118). In Methanosarcina species, HdrA2 is composed of a homolog of MvhD (as 
found in the MvhADG:HdrABC enzyme complex of cytochrome-deficient 
methanogens) fused to the C-terminus of a HdrA homolog, where it likely has a 
function in electron transport (99). In the proposed bifurcation mechanism, 
endergonic reduction of Fd (E°’≈ -500 mV) by oxidation of F420red (E°’= -360 mV) 
is facilitated by the exergonic reduction of CoM-CoB (E°’= -140 mV) by F420red. 
The reaction (Fdox + CoM-CoB + 2 F420red o Fdred + CoM + CoB + 2 F420ox) is 
energetically favorable, with a free energy of ΔG°’≈ -30 kJ per mole (21). 
Although biochemically characterized, the in vivo role for this FBEB mechanism 
in Methanosarcina species has not been fully established. Indeed, a modified 
strain of M. acetivorans that does not produce HdrA2B2C2 is unaffected during 
growth with most substrates, with the exception of slower growth with acetate 
(19). As F420 is not required for the aceticlastic pathway, it is not clear how this 
form of FBEB integrates into energy conservation network of methanogens with 
cytochromes. 
 
Electron transport in methanogens with cytochromes 
 In contrast to methanogens without cytochromes, which can only establish 
a transmembrane Na+ gradient via Mtr, methanogens with cytochromes have 
several mechanisms for establishing an ion gradient via a membrane-bound 
electron transport system (32, 103). In each mechanism, the CoM-CoB disulfide 
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serves as the terminal electron acceptor and H+ or Na+ ions are translocated 
across the membrane (31). However, the electron transport mechanisms vary by 
the electron source (F420red, Fdred, or H2), and by whether the organism can 
utilize H2 as a substrate (Figures 1.6 & 1.7). Production of simultaneous H+ and 
Na+ electrochemical ion gradients is a unique characteristic of these 
methanogens, and efficient energy conservation requires both electrical 
potentials be used for generation of ATP (81). Recent evidence indicates the 
A1AO ATP synthase from M. acetivorans can translocate both H+ and Na+ ions for 
ATP synthesis, a property that is potentially shared by other Methanosarcina 
species (91). Alternatively, these organisms may use a Na+/H+ antiporter, such 
as Mrp, to convert one ion gradient into the other, or to optimize the ion ratio for 
the ATP synthase (32, 57). Lastly, the additional ion-translocation mechanisms in 
methanogens with cytochromes allows for higher growth yields than 
methanogens without cytochromes (103). 
 All species of Methanosarcina have a H2-independent F420red:CoM-CoB 
electron transport pathway (32, 115). During methylotrophic methanogenesis, 
F420red (E°’= -360 mV) is produced during the oxidation of methyl groups to CO2, 
and CoM-CoB (E°’= -140 mV) is produced during the reduction of methyl groups 
to methane (Figure 1.4). Therefore, the F420red:CoM-CoB electron transport 
pathway allows for the transfer of reducing equivalents between the oxidative 
and reductive branches of methylotrophic methanogenesis, while also conserving 
energy in the form of an electrochemical H+ gradient . The 14-subunit F420 
dehydrogenase (FpoABCDFHIJJKLMNO) and a heterodisulfide reductase 
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(HdrED) facilitate the H2-independent version of this system, wherein oxidation of 
F420red by Fpo and reduction of CoM-CoB by HdrED are linked by the membrane 
soluble electron carrier, methanophenazine (MP; Figure 1.6) (5, 8, 25, 114). The 
initial reduction of MP with electrons from F420red is exergonic (ΔG°’= -37.6 kJ 
per mole), which allows 2 H+ to be translocated to the outside of the cell by Fpo 
(6). Analysis of the amino acid sequence of Fpo from Methanosarcina species 
indicates a high level of similarity to the NADH:quinone oxidoreductases 
(complex I) of bacteria and eukaryotes, which are also H+-translocating enzyme 
complexes (115). An additional 2 H+ are moved across the membrane during the 
transfer of electrons from MPred to CoM-CoB via HdrED, for a total of 4 H+ 
translocated for every 2 electrons transported by the F420red:CoM-CoB system. 
The HdrE subunit is a membrane-bound, heme b-containing cytochrome, and it 
has been suggested that protons are translocated by a mechanism similar to that 
of the bacterial quinone-loop (the MP-loop) (64, 95). Reduction of CoM-CoB 
occurs at the active site of HdrD with electrons obtained from HdrE, thereby 
completing the electron transport pathway and regenerating the free CoM and 
CoB thiols for further rounds of methanogenesis (52). 
 Some species of Methanosarcina, such as M. acetivorans, also have a H2-
independent Fdred:CoM-CoB electron transport pathway. With this system, Fdred 
generated by the oxidation of an enzyme-bound carbonyl group to CO2 in the 
aceticlastic pathway (Figure 1.3) or by the oxidation of formyl-MF to CO2 in the 
methylotrophic pathway (Figure 1.4) is used to reduce the terminal electron 
acceptor, CoM-CoB. In a mechanism similar to the F420red:CoM-CoB pathway, 
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Figure 1.6. The H2-independent electron transport system of 
Methanosarcina. Electrons enter the transport system as either reduced 
coenzyme F420 (F420red) or reduced ferredoxin (Fdred), and are used for the 
reduction of the terminal electron acceptor, CoM-CoB. Reduction of CoM-CoB by 
the heterodisulfide reductase (Hdr) regenerates coenzyme M (CoM) and 
coenzyme B (CoB) for continued methanogenesis. F420 dehydrogenase (Fpo) 
catalyzes the exergonic transfer of electrons from F420red to methanophenazine 
(MP) with concomitant translocation of 2 H+ to the outside of the cell. Similarly, 
the Rnf enzyme complex facilitates the exergonic transfer of electrons from Fdred 
to MP, but instead translocates 3 Na+ outside of the cell. In both pathways, an 
additional 2 H+ are consumed from the cytoplasm during MP reduction, and 
released outside of the cell upon MP oxidation. Thus, the transport of 2 electrons 
results in 4 H+ translocated for the F420red:CoM-CoB pathway and 3 Na+ + 2 H+ 
translocated for the Fdred:CoM-CoB pathway (indicated in red). Enzyme subunits 
are identified by letters, with the exception of the cytochrome c subunit (Cyt c) 
and a membrane-integral subunit with unknown function (*) that are co-
transcribed with the rest of the rnf operon. Oxidized and reduced states of 
electron carriers are indicated by ox/red subscripts. 
 
electrons from the reduced electron carrier (Fdred) are transferred to MP, which is 
used by HdrED to reduce CoM-CoB. The exergonic transport of electrons from 
Fdred to MPox (ΔG°’= -68 kJ per mole) is facilitated by the membrane-bound, Na+-
translocating enzyme complex, Rnf (Figure 1.6) (67, 92, 100, 112). It is estimated 
that 3 Na+ are translocated for every 2 electrons transported by Rnf (9, 92). 
Combining this value with protons translocated by the HdrED-mediated MP-loop 
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brings the electrochemical total to 3 Na+ & 2 H+ moved to the outside of the cell 
for every 2 electrons that pass through the Fdred:CoM-CoB electron transport 
pathway. The Rnf complex has been identified in a wide array of bacterial 
species, and typically catalyzes Fdred:NAD+ oxidoreductase activity with 
concomitant Na+ translocation (10). However, it has been shown that Rnf from 
Methanosarcina does not interact with NADH/NAD+ (92, 112). Additionally, the 
gene cluster encoding Rnf (rnfCDGEAB) differs from all known bacterial versions 
by encoding a c-type cytochrome upstream of rnfC and a gene downstream of 
rnfB that is predicted to integrate into the membrane. Both genes are co-
transcribed with the rest of the rnf operon, and it is thought that the cytochrome c 
subunit is responsible for transferring electrons to MP (67). 
 Methanosarcina species that are able to metabolize H2, such as M. barkeri, 
have a H2-dependent electron transport system, wherein H2 can serve as the 
sole source of electrons (H2:CoM-CoB pathway) or as an intermediate 
(Fdred:CoM-CoB and F420red:CoM-CoB pathways). In all three, the transport of 
electrons from H2 to CoM-CoB (i.e. the H2:CoM-CoB pathway) occurs by the 
same mechanism; only the source of H2 varies between the pathways (Figure 
1.7). Electron transport is initiated by the membrane-bound Vht hydrogenase, 
which oxidizes H2 at an externally located active site. Electrons are then 
transferred to MP by way of the cytochrome b-containing subunit (VhtC) (29, 31, 
53). HdrED facilitates the transfer of electrons from MPred to CoM-CoB, as 
described above for H2-independent electron transport systems. Oxidation of H2 
by Vht produces 2 external H+, which, when combined with translocated protons 
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from the MP-loop, results in a total proton motive force of 4 H+ per 2 electrons 
transported (53). 
  As will be discussed in Chapter 2, the only electron source for the CO2 
reduction (Figure 1.2) and methyl reduction (Figure 1.5) methanogenic pathways, 
is externally provided H2, and the H2:CoM-CoB electron transport pathway is 
used. However, metabolism of acetate and methyl compounds via the 
aceticlastic and methylotrophic pathways produces internal electron sources 
(Fdred and F420red) as described above. The transport of electrons from Fdred and 
F420red to CoM-CoB via the H2-dependent electron transport pathways involves a 
hydrogen cycling mechanism (Figure 1.7) (63, 74, 75). In the first part of this 
mechanism, Fdred and F420red are oxidized by the Ech and Frh hydrogenases, 
respectively, and electrons are used to generate H2 on the inside of the cell. The 
H2 then diffuses across the membrane to the Vht active site, where it is oxidized 
and electrons are transported to CoM-CoB via the H2:CoM-CoB electron 
transport pathway. The hydrogen cycling mechanism was confirmed in a series 
of hydrogenase mutants, wherein removal of Vht caused rapid accumulation of 
H2, diminished methanogenesis, and cell death. However, when both Vht and 
Frh were removed this effect was abrogated, indicating Vht is required to capture 
H2 produced by Frh in order to maintain redox balance (63). The production of H2 
inside the cell consumes 2 internal H+, and oxidation by Vht produces 2 external 
H+. Combined with protons translocated via the MP-loop yields a total of 4 H+ 
moved across the membrane for 2 electrons that pass through the electron 
transport chain (62, 63). Additional energy is conserved by the proton-pumping  
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Figure 1.7. The H2-dependent electron transport system of Methanosarcina. 
Electrons enter the transport system as either externally provided H2 or internally 
generated reduced ferredoxin (Fdred) or reduced coenzyme F420 (F420red). All 
pathways involve the oxidation of H2 by the Vht hydrogenase, and the transport 
of electrons by methanophazine (MP) to the heterodisulfide reductase (Hdr) for 
reduction of the terminal electron acceptor, CoM-CoB. Regeneration of 
coenzyme M (CoM) and coenzyme B (CoB) enables continued methanogenesis. 
The Frh and Ech hydrogenases generate H2 with electrons from F420red and 
Fdred, respectively. The internally produced H2 diffuses across the membrane 
(dashed line) and is oxidized by Vht, thereby transferring 2 H+ from the inside to 
the outside of the cell. The exergonic reaction catalyzed by Ech facilitates 
additional proton translocation. For each pathway, 2 H+ are consumed from the 
cytoplasm during MP reduction, and released outside of the cell upon MP 
oxidation. Thus, the transport of 2 electrons results in 4 H+ translocated for the 
F420red:CoM-CoB pathway and 5 H+ translocated for the Fdred:CoM-CoB pathway 
(indicated in red). Enzyme subunits are identified by letters; oxidized and 
reduced states of electron carriers are indicated by ox/red subscripts. 
 
Ech hydrogenase during the generation of H2 from Fdred, as this exergonic 
reaction enables auxiliary proton translocation (113). Thus, a similar amount of 
energy is conserved as an ion motive force by the H2-dependent and H2-
independent electron transport systems (97).  As highlighted by the use of H2 as 
an electron source and as an electron carrier, this molecule serves as an 
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important metabolite, and the hydrogenase enzymes that enable its use are an 
essential component of methanogenic energy conservation systems. 
 
Hydrogenases of Methanosarcina 
 Organisms from all three domains of life rely on the activity of 
hydrogenases in order to consume H2 as a substrate or to produce H2 from the 
reduction of protons. Hydrogenases belong to a large and diverse group of 
enzymes, and are classified into groups based on cognate electron carrying 
redox partner (NAD+, Fd, F420, MP, etc.), active site cofactors ([NiFe], [FeFe], or 
[Fe]), location within the cell (membrane-bound or cytoplasm), or the ability to 
conserve energy by ion translocation (87, 110). Methanogens use five different 
types of hydrogenase. Two are found in methanogens without cytochromes, but 
are lacking in methanogens with cytochromes, and one is a cytochrome-
containing hydrogenase (Vht) that is only found in Methanosarcina species (104). 
Hydrogenases found only in cytochrome-deficient methanogens include the 
MvhADG hydrogenase that is HdrABC-associated and used for FBEB, and a 
unique nickel-free [Fe]-hydrogenase that is only found in methanogenic archaea 
(94, 99, 104, 119). Under nickel-limiting conditions, the [Fe]-hydrogenase 
replaces the F420-reducing [NiFe] hydrogenase activity required for the reduction 
of methenyl-H4MPT and methylene-H4MPT (Figure 1.2) (1, 2). The other four 
hydrogenases found in methanogens belong to the [NiFe] group of hydrogenases, 
as classified by the active site transition-metals used for catalysis (87). The core 
of all [NiFe] hydrogenases consists of a heterodimer containing a “large” and a 
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“small” subunit. The large subunit contains the [NiFe] active site, and the small 
subunit typically contains 3 linearly arranged Fe-S clusters of the cubane 
[4Fe4S]-type, which facilitate electron transport between the active site and 
cognate redox partner (110). Despite different mechanisms for energy 
conservation between methanogens with and without cytochromes, two types of 
[NiFe] hydrogenases are present in both methanogen classes. This includes a 
membrane-bound energy-converting hydrogenase, such as the Ech hydrogenase 
found in M. barkeri, and a cytoplasmic F420-reducing hydrogenase, such as Frh.  
 
The energy-converting hydrogenase 
 The membrane-bound, energy-converting [NiFe] hydrogenases are 
evolutionarily distinct from other hydrogenases based on amino acid sequence 
alignments (109, 110). Aside from the conserved residues required to coordinate 
the [NiFe] active site and Fe-S clusters, this type of hydrogenase has very little 
sequence similarity to other [NiFe] hydrogenases (50). Additionally, the core of 
energy-converting hydrogenases contains at least six subunits; two membrane-
bound hydrophobic subunits, two soluble hydrophilic subunits, and the large and 
small hydrogenase subunits. These six subunits, as typified by Ech from M. 
barkeri (Figure 1.8), are highly similar to the subunits that form the catalytic core 
of the ion-translocating NADH:quinone oxidoreductase (complex I) of 
mitochondria and bacteria (50, 51). In fact, energy-converting hydrogenases are 
predicted to be ancestral to complex I because they can be found in organisms 
thought to have an ancient form of metabolism (50). 
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Figure 1.8. The energy-converting 
hydrogenase (Ech) of M. barkeri. The 
Ech hydrogenase consists of 6 subunits 
(EchABCDEF), of which EchA and 
EchB are membrane-bound and EchA is 
the likely location for H+ translocation. 
The remaining 4 subunits are located in 
the cytoplasm, and facilitate the transfer 
of electrons between ferredoxin (Fd) 
and H2/H+ by way of 3 cubane Fe-S 
clusters ([4Fe4S]). EchE contains the bi-
metalic [NiFe] active site for H2 
formation/oxidation. Bidirectional arrows 
indicate Ech is a reversible enzyme. In 
one direction, the exothermic oxidation 
of reduced Fd (Fdred) allows for internal 
H2 production and translocation of H2 to 
the outside of the cell. 
 
 Species of Methanosarcina that are able to utilize H2 as a substrate 
encode an energy-converting hydrogenase. Initial identification of this enzyme in 
M. barkeri indicated that it was highly similar to Escherichia coli-3-type 
hydrogenase, and it was thereby designated as Ech (65, 74). Further elucidation 
of the coupled hydrogenase and ion-translocating activities of this enzyme 
conferred a more appropriate “energy-converting hydrogenase” definition for Ech 
(109). This 6-subunit enzyme (EchABCDEF) drives the endergonic reduction of 
Fd (E°’≈ -500 mV) with electrons from H2 oxidation (E°’= -414 mV) by utilizing the 
proton motive force (Figure 1.8) (17, 50, 74). Ech is also reversible, such that 
oxidation of Fdred leads to both the generation of H2 and the translocation of H+ 
outside of the cell (16, 18, 113). EchA and EchB are the membrane-bound 
subunits, with EchA being the most probable location for H+ translocation based 
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on sequence similarity to ion translocating proteins in other organisms. The large 
and small hydrogenase subunits, EchE and EchC, are soluble and located within 
the cytoplasm. EchE contains the [NiFe] active site, and EchC contains only one 
[4Fe4S] cluster, which distinguishes it from the small subunit of other [NiFe] 
hydrogenases that typically have three clusters. However, another subunit, EchF, 
contains two additional [4Fe4S] clusters, and is the location of Fd 
oxidation/reduction (40, 50, 104). Studies of a M. barkeri mutant lacking Ech 
indicate that this hydrogenase is required for the CO2 reduction and aceticlastic 
pathways (Figures 1.2 & 1.3). Additionally this mutant strain requires 
supplementation with biosynthetic precursors during growth via the methyl 
reduction pathway (Figure 1.5), indicating Ech is required to provide the Fdred 
needed for pyruvate and acetyl-CoA synthesis (75). 
 
The coenzyme F420-reducing hydrogenase 
 The F420-reducing hydrogenase (Frh) has a critical role in the CO2 
reduction pathway of methanogenesis (Figure 1.2) by providing F420red required 
for two reduction steps. Thus, all methanogens that are able to reduce CO2 with 
H2-derived electrons require an Frh hydrogenase. As such, this enzyme has 
been purified from methanogens with and without cytochromes (4, 39, 41, 56, 82). 
Frh is a reversible enzyme that catalyzes the reduction of F420 with electron 
obtained by the oxidation of H2 (Figure 1.9). Under standard conditions this 
reaction has a free energy change of ΔG°’= -11 kJ per mole. However, under in 
vivo conditions there is very little free energy change, and Frh activity is therefore 
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not directly coupled to energy conservation (104). In fact, the redox state of F420 
has been found to be in equilibrium with the external concentration (partial 
pressure) of H2 (23, 63). 
Figure 1.9. The coenzyme F420-reducing 
hydrogenase (Frh). Frh is a heterotrimeric 
enzyme, consisting of a large subunit (FrhA), 
small subunit (FrhG), and a flavin adenine 
dinucleotide (FAD)-containing subunit (FrhB). 
FrhA contains the [NiFe] active site for 
formation or oxidation of H2, and FrhB has 
an FAD-containing active site for coenzyme 
F420 oxidation or reduction (F420ox/F420red). 
Electrons are transmitted between active 
sites by four cubane Fe-S clusters ([4Fe4S]) 
located in FrhG and FrhB. Bidirectional 
arrows indicate Frh is a reversible enzyme. 
 
 Initial purification and characterization of Frh indicated the core of this 
hydrogenase consists of three subunits (FrhAGB) that form a membrane-
associated heterotrimer (3, 39, 70). However, Frh was later found to be located 
within the cytoplasm and not membrane-bound, as none of the subunits contain 
transmembrane helices. Additionally, during purification it was found that Frh 
forms a complex consisting of at least 8 of the heterotrimers (3, 39). Recently, 
the structure of Frh from Methanothermobacter marburgensis was determined by 
cryo-electron microscopy, which confirmed that this hydrogenase forms a large 
complex (78). The structure determination also verified the locations of key 
components for electron transport in this enzyme: the [NiFe] active site, [4Fe4S] 
clusters, and flavin adenine dinucleotide (FAD; Figure 1.9). FrhA is the large 
hydrogenase subunit, and contains the bi-metallic [NiFe] active site for H2 
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oxidation or formation. FrhB facilitates F420 redox reactions with an FAD-
containing active site. Transport of electrons between the [NiFe] and FAD active 
sites occurs via four [4Fe4S] clusters. Three of these clusters are located in the 
small hydrogenase subunit, FrhG, and the fourth is located within FrhB (78, 104). 
 Whereas methanogens without cytochromes solely use Frh to produce 
F420red from H2 for two sequential reduction steps in the CO2 reduction pathway, 
methanogens with cytochromes are also able to take advantage of the 
reversibility of Frh during methylotrophic methanogenesis (Figure 1.4) (62, 63). In 
this pathway, F420red generated by the oxidation of methyl groups to CO2 is 
oxidized by Frh to form H2. Diffusion of H2 to the external Vht hydrogenase active 
site allows electrons from F420red to enter the electron transport system by way 
of the hydrogen cycling mechanism discussed above (63). A mutant strain of M. 
barkeri that lacks the Frh hydrogenase is still able to utilize the methylotrophic 
pathway for methanogenesis; however, the growth rate and final yield are 
severely diminished, indicating the Frh-Vht mediated hydrogen cycling 
mechanism is the preferred method of electron transport (62). Thus, Frh plays an 
important role in both the CO2 reduction and methylotrophic pathways. 
 
The methanophenazine-reducing hydrogenase 
 Only methanogens with cytochromes have a MP-reducing hydrogenase, 
where it plays a critical role in all four methanogenic pathways. Vht (as the MP-
reducing hydrogenase is designated in M. barkeri) catalyzes the exergonic 
reduction of MP with electrons obtained by the oxidation of H2 (ΔG°’= -50 kJ per 
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mole) (103). Energy is conserved by the production of 2 external H+ from H2 
oxidation at the Vht active site on the outside of the cell, thereby contributing to 
the electrogenic transmembrane proton gradient (115). The Vht-generated MPred 
is then used for reduction of the terminal electron acceptor common to all 
methanogenic pathways, CoM-CoB, as described for the H2-dependent electron 
transport system (31, 53). During methanogenesis via the CO2 reduction and 
methyl reduction pathways H2 is provided externally, and for the aceticlastic and 
methylotrophic pathways H2 is produced internally by the Ech and Frh 
hydrogenases (63, 74, 75). The inability of an M. barkeri mutant strain lacking 
Vht to grow on any substrate supports the essentiality of Vht in Methanosarcina 
strains that rely on H2 as a substrate and for electron transport (63). 
 
Figure 1.10. The methanophenazine-reducing 
hydrogenase (Vht) of M. barkeri. The large 
hydrogenase subunit (VhtA) is located on the 
outside face of the cytoplasmic membrane and 
contains the bi-metallic [NiFe] active site where 
H2 is oxidized. This reaction generates 2 external 
H+ that contribute to proton motive force, and 2 
electrons that are transported via Fe-S clusters 
([4Fe4S] & [3Fe4S]) located in the small subunit 
(VhtG) to heme b groups in the membrane-
bound cytochrome b subunit (VhtC). Reduction 
of the electron carrier methanophenazine (MP) 
by VhtC involves uptake of 2 H+ from the 
cytoplasm, which are released externally upon 
MP oxidation (not shown). The redox state of MP 
is indicated by red/ox subscripts. 
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 The Vht hydrogenase was first characterized from cell extracts of 
Methanosarcina mazei and M. barkeri. Initial purification of Vht from membrane 
fractions indicated that it was a two-subunit, membrane-bound hydrogenase (26, 
61). These subunits consisted of VhtA, the large subunit containing the [NiFe] 
active site, and VhtG, the small subunit containing three Fe-S clusters (Figure 
1.10). The third subunit, VhtC, was later identified by experiments searching for 
genes that encode Vht, as the vht operon contains genes for all three subunits 
(27, 28). VhtC is a membrane spanning cytochrome b protein that contains two 
heme b prosthetic groups as the location for MP reduction. The VhtA and VhtG 
subunits were determined to be located on the outer face of the cell membrane 
based on the presence of a twin-arginine-translocation (Tat) signal peptide on the 
N-terminus of VhtG, and on the high level of homology to cytochrome b-
containing hydrogenases from bacterial species that are located in the periplasm 
(34, 104, 117). Thus, the external active site of Vht allows for the extraction of 
electrons from H2 while simultaneously contributing to the proton gradient, which 
can be used to generate ATP. 
 
Thesis overview 
 The overlapping metabolic pathways of Methanosarcina species allow 
these organisms to use a comparatively large number of substrates for growth 
and methanogenesis. While the methanogenic pathways have been broadly 
characterized, some important details, such as the involvement of hydrogenases 
in electron flow and energy conservation during methylotrophic methanogenesis, 
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remain unsolved. In the second chapter of this thesis, I describe a project in 
which we characterized the biochemical and molecular effects of deleting the 
genes for each hydrogenase of M. barkeri in all possible combinations. We found 
that while hydrogenases enable quick and efficient methylotrophic 
methanogenesis, a strain of M. barkeri that lacks all hydrogenases is still able to 
utilize this metabolic pathway (72). The strain of M. barkeri lacking all 
hydrogenases is reminiscent of M. acetivorans, a species of Methanosarcina that 
is unable to utilize H2 as a substrate and lacks all hydrogenase activity. Despite 
the inability to use H2, M. acetivorans encodes two of the three hydrogenases 
utilized by M. barkeri (Frh and Vht) with a high level of amino acid sequence 
identity (46, 47). In the third chapter, I describe a project in which I examined the 
mechanism by which M. acetivorans regulates and specifically inactivates 
hydrogenases. I found that regulation occurs at the transcriptional, translational, 
and post-translational levels. Lastly, with the final chapter I describe several lines 
of investigation that I have initiated which lay the groundwork for future studies 
on regulatory mechanisms and enzyme interactions in Methanosarcina. 
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Chapter 2: Genetic, biochemical, and molecular characterization of 
Methanosarcina barkeri mutants lacking three distinct classes of 
hydrogenase1  
 
The methanogenic archaeon Methanosarcina barkeri encodes three 
distinct types of hydrogenase, whose functions vary depending on the growth 
substrate. These include the F420-dependent (Frh), methanophenazine-
dependent (Vht), and ferredoxin-dependent (Ech) hydrogenases. To investigate 
their physiological roles, we characterized a series of mutants lacking each 
hydrogenase in various combinations. Mutants lacking Frh, Vht, or Ech in any 
combination failed to grow on H2-CO2, whereas only Vht and Ech were essential 
for growth on acetate. In contrast, a mutant lacking all three grew on methanol 
with a final growth yield similar to wild-type, produced methane and CO2 in the 
expected 3:1 ratio, but had a ca. 33% slower growth rate. Thus, hydrogenases 
play a significant, but non-essential, role during growth on this substrate. As 
previously observed, mutants lacking Ech fail to grow on methanol-H2 unless 
they were supplemented with biosynthetic precursors. Interestingly, this 
phenotype was abolished in the ∆ech/∆frh and ∆ech/∆frh/∆vht mutants, 
consistent with the idea that hydrogenases inhibit methanol oxidation in the 
presence of H2, which prevents production of reducing equivalents needed for 
biosynthesis.  Quantification of methane and CO2 produced from methanol by 
resting cell suspensions of various mutants supports this conclusion. On the 
 
1 The research performed in this chapter was jointly conducted by me and Dr. Gargi Kulkarni. 
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basis of global transcriptional profiles, none of the hydrogenases were 
upregulated to compensate for loss of the others. However, the transcript levels 
of the F420 dehydrogenase operon were significantly higher in all strains lacking 
frh, suggesting a mechanism to sense the redox state of F420. The roles of the 
hydrogenases in energy conservation during growth with each methanogenic 
pathway are discussed.  
 
Importance  
Methanogenic archaea are key players in the global carbon cycle due to 
their ability to facilitate the remineralization of organic substrates in many 
anaerobic environments. The consequences of biological methanogenesis are 
far reaching, with impacts on atmospheric methane and CO2 concentrations, 
agriculture, energy production, waste treatment and human health. The data 
presented here clarify the in vivo function of hydrogenases during 
methanogenesis, which in turn deepens our understanding of this unique form of 
metabolism. This knowledge is critical for a variety of important issues ranging 
from atmospheric composition to human health.  
 
Introduction 
The ability to metabolize molecular hydrogen (H2) is a key metabolic 
feature in methanogenic Archaea (36).  This trait is conferred by a class of 
enzymes known as hydrogenases, which catalyze the reversible oxidation of H2 
coupled to various electron donors/acceptors (29, 40). At least five distinct types 
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of hydrogenases are found in methanogenic archaea. These enzymes differ with 
respect to their redox partners, their cellular localization, and whether their 
activity is linked to production or consumption of membrane potential (38).  
Biochemical characterization of these diverse hydrogenases led to proposed 
functions for each enzyme class that differ substantially between methanogens 
with and without cytochromes (37).  
Methanogens without cytochromes produce at least four types of 
hydrogenase; including (i) the electron-bifurcating Mvh hydrogenase, which 
couples oxidation of hydrogen to reduction of ferredoxin and a mixed coenzyme 
M-coenzyme B disulfide, (ii) the coenzyme F420-dependent hydrogenase, (iii) 
the [Fe] hydrogenase, which couples hydrogen oxidation to reduction of 
methenyltetrahydromethanopterin, and (iv) the ferredoxin-dependent, energy-
converting hydrogenases (38). The first three are cytoplasmic enzymes, which 
supply the electrons needed to reduce CO2 to methane.  The last is a membrane 
bound multi-subunit complex that couples hydrogenase activity to the 
production/consumption of the ion-motive force across the cell membrane (hence 
the designation as “energy-converting”).  In non-cytochrome-containing 
methanogens, these energy-converting hydrogenases are believed to provide 
low-potential electrons, in the form of reduced ferredoxin, needed for anaplerotic 
reactions (20). 
Methanogens with cytochromes, typified by Methanosarcina barkeri, 
encode a different set of hydrogenases that includes one cytoplasmic and two 
membrane-bound enzymes (Figure 2.1) (13). Like the non-cytochrome 
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containing methanogens, M. barkeri produces a cytoplasmic, three-subunit F420-
dependent hydrogenase known as Frh (for F420-reducing hydrogenase). Frh is 
encoded by the four-gene frhADGB operon, which encodes the α, β, and γ 
subunits (FrhA, FrhB and FrhG, respectively), along with the maturation protease 
FrhD (39).  A second locus, freAEGB, encodes proteins that are 86-88% identical 
to FrhA, FrhB and FrhG, but lacks the gene for the maturation protease FrhD, 
instead encoding a small protein of unknown function (FrhE).  It is not known 
whether the fre operon is capable of producing an active hydrogenase (8, 17, 27, 
39). A membrane-bound hydrogenase linked to the quinone-like electron carrier 
methanophenazine has, to date, been found only in Methanosarcina species. 
This enzyme, known as Vht because it was initially identified as a viologen-
reducing hydrogenase, is encoded by the vhtGACD operon, which encodes the 
biochemically characterized enzyme comprised of VhtA and VhtG, along with a 
putative membrane-bound cytochrome, VhtC, that does not co-purify with the 
active enzyme, and a maturation protease, VhtD (13). As with the F420-reducing 
hydrogenase, a second locus that lacks the maturation protease is encoded in M. 
barkeri strains. This operon (vhxGAC) encodes proteins that display ca. 50% 
amino acid identity with those encoded by vhtGACD. Like freAEGB, it is not 
known whether the vhx operon produces an active hydrogenase (13). Finally, M. 
barkeri encodes a membrane-bound, ferredoxin-dependent energy-converting 
hydrogenase (Ech) (25). This five-subunit enzyme complex is much simpler than, 
and only distantly related to, the energy-converting hydrogenases of the non-
cytochrome methanogens, which typically contain more than a dozen subunits 
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(29). Cytochrome-containing methanogens are not known to contain homologs of 
the electron bifurcating- and methenyltetrahydromethanopterin-reducing 
hydrogenases.  
 
 
Figure 2.1. Hydrogenase operons of Methanosarcina barkeri. Three distinct 
types of hydrogenase are encoded by M. barkeri. Two potential 
methanophenazine-dependent hydrogenases are encoded by the adjacent 
vhtGACD and vhxGAC operons, while two potential F420-dependent 
hydrogenases are encoded by the unlinked frhADGB and freAEGB operons.  
The energy-converting, ferredoxin-dependent hydrogenase is encoded by the 
echABCDEF operon.  Locus Tags are shown below each gene, in some cases 
the “Mbar_” prefix was omitted (shown by an asterisk) due to space constraints. 
 
A key difference between the cytochrome-containing and non-cytochrome-
containing methanogens is the ability of the former to use one-carbon (C1) 
compounds and acetic acid, in addition to H2-CO2, as growth substrates. 
Catabolism of these chemically diverse substrates involves four distinct 
methanogenic pathways: the CO2 reduction pathway, the methyl reduction 
pathway, the methylotrophic pathway and the aceticlastic pathway (11, 21). 
While several of these pathways share common steps, they differ substantially 
with respect to involvement of key enzymes and the direction of metabolic flux 
during methane production (Figure 2.2).  Surprisingly, it now appears that some 
Methanosarcina species (e.g. M. barkeri) use hydrogenases in each of the four 
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pathways, regardless of whether external H2 is provided as a growth substrate 
(18). 
During the CO2 reduction pathway, wherein CO2 is reduced to CH4 in a 
stepwise manner, hydrogenases produce the electron-donating cofactors 
required for four distinct reduction steps (Figure 2.2) (37). Initial reduction of CO2 
to formyl-methanofuran requires reduced Fd (Fdred), which is produced by Ech. 
This reaction is dependent on an ion-motive force because reduction of Fd by H2 
is endergonic under physiological conditions (26). Subsequent reductions of 
methenyl-tetrahydrosarcinapterin (H4SPT) to methylene-H4SPT, and of 
methylene-H4SPT to methyl-H4SPT, require reduced coenzyme F420 (F420red), 
which is supplied by Frh. Finally, reduction of a methyl group to methane using 
coenzyme B produces a heterodisulfide of coenzyme M and coenzyme B (CoM-
S-S-CoB), which must be reduced to produce the free CoM and CoB needed for 
continued methanogenesis. This reaction is catalyzed by a membrane bound 
heterodisulfide reductase (HdrED), which uses the reduced form of a membrane-
bound cofactor, methanophenazine, as the source of electrons (7). H2, in turn, 
serves as the reductant for generation of reduced methanophenazine via 
membrane-bound Vht hydrogenase. Thus, all three types of hydrogenase are 
predicted to be required for growth via CO2 reduction, a conclusion that has been 
validated by the phenotypic analysis of single mutants (17, 18, 26). 
In contrast, methanogenesis via the methyl reduction pathway is expected 
to require only Vht. In this pathway, methyl-CoM derived from C1 compounds, 
such as methanol or methylamines, is directly reduced to methane using CoB as 
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Figure 2.2. Four methanogenic pathways of Methanosarcina. Each pathway 
shares a common step in the reduction of methyl-CoM to methane; however, 
they differ in the route used to form methyl-CoM and in the source of electrons 
used for its reduction to methane. The CO2 reduction pathway (red arrows) 
involves reduction of CO2 to methane using electrons derived from the oxidation 
of H2, while the methylotrophic pathway (light blue arrows) involves 
disproportionation of C1 substrates to methane and CO2. These two pathways 
share many steps, with overall metabolic flux in opposite directions (shown by 
red/light blue shaded arrows). In the aceticlastic pathway (green arrows), acetate 
is split into a methyl group and an enzyme-bound carbonyl moiety (shown in 
brackets) by the enzyme acetyl-CoA decarbonylase/synthase (ACDS). The latter 
is oxidized to CO2, producing reduced ferredoxin that provides electrons for 
reduction of methyl group to methane. Lastly, in the methyl reduction pathway 
(dark blue arrows) C1 compounds are reduced to CH4 using electrons derived 
from H2 oxidation. Dashed lines depict diffusion of H2, which occurs during the 
transfer of electrons between oxidative and reductive portions of methylotrophic 
and aceticlastic pathways. The steps catalyzed by Frh, Vht, Ech hydrogenases 
are indicated. Note that in wild-type M. barkeri, hydrogenases are involved in all 
four pathways. Abbreviations used are: Hdr, heterodisulfide reductase; MF, 
methanofuran; H4SPT, tetrahydrosarcinapterin; CoM, coenzyme M; CoB, 
coenzyme B; CoM-S-S-CoB, heterodisulfide of CoM and CoB; Fdox/Fdred, 
oxidized and reduced ferredoxin; F420ox/F420red, oxidized and reduced cofactor 
F420; MPox/MPred, oxidized and reduced methanophenazine. 
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the electron donor. As with the CO2 reduction pathway, this produces a CoM-S-
S-CoB disulfide that must be regenerated in a pathway requiring HdrED and 
reduced methanophenazine, which is presumably generated by Vht (Figure 2.2). 
This idea is supported by the analysis of conditional vht mutants (18). Neither Frh 
nor Ech is required for methanogenesis in this model, a finding that is consistent 
with experimental data from Δfrh and Δech mutants (17, 26). Nevertheless, the M. 
barkeri Δech strain cannot grow via the methyl reduction pathway unless the 
media are supplemented with acetate and/or pyruvate. Thus, Ech plays an 
essential biosynthetic role under these conditions, which is probably the H2-
dependent synthesis of reduced ferredoxin needed for synthesis of acetyl-CoA 
and pyruvate (26).   
During aceticlastic methanogenesis, both the Ech and Vht hydrogenases 
play a critical role in methanogenesis. In this pathway, acetyl-CoA is split into 
methyl-H4SPT and enzyme-bound [CO] by the acetyl-CoA 
decarbonylase/synthase (ACDS) enzyme complex. CO is then further oxidized to 
CO2 with concomitant reduction of ferredoxin (25, 26). It is believed that the 
exergonic oxidation of ferredoxin by Ech produces H2 and contributes to the 
proton motive force by transferring protons across the membrane. The proton 
motive force is further enhanced by a putative H2 cycling mechanism, in which 
the H2 produced by Ech diffuses across the membrane, where it is oxidized by 
Vht to produce reduced methanophenazine. This unusual electron transport 
chain is completed when the reduced methanophenazine produced by Vht is 
used by HdrED to regenerate free CoM and CoB from the CoM-S-S-CoB 
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heterodisulfide (Figure 2.2) (43). Participation of these hydrogenases in the 
aceticlastic pathway is supported by mutagenic studies showing that ech and vht 
mutants do not grow with acetate as the sole substrate, regardless of whether 
biosynthetic precursors were supplied (18, 26). 
Finally, all three types of hydrogenases are thought to be involved in 
methylotrophic methanogenesis via a H2 cycling mechanism similar to that 
described for aceticlastic growth (18). In this pathway, F420red and Fdred, 
produced by the stepwise oxidation of methyl groups to CO2, are converted to 
molecular H2 by Frh and Ech, respectively (Figure 2.2). H2 then diffuses to the 
outer surface of the cell membrane where it is oxidized by Vht, releasing protons 
on the outside of the cell and contributing to the generation of an ion-motive force 
(Figure 2.3) (18). Electrons from the oxidation of H2 are used to regenerate CoM 
and CoB via HdrED, as described for the aceticlastic pathway above. 
Nevertheless, M. barkeri Δfrh and Δech strains are capable of methylotrophic 
growth, indicating the presence of alternative pathways for transfer of electrons 
from F420red and Fdred to the electron transport chain (17, 26). The membrane-
bound F420 dehydrogenase complex (Fpo) has been identified as the alternate 
mechanism of electron transfer from F420red (17). This enzyme couples the 
exergonic reduction of methanophenazine by F420red, with the generation of 
proton motive force in a H2 independent manner. However, the M. barkeri Δfrh 
strain exhibits slower growth rates than wild type M. barkeri, showing that the H2-
independent electron transport chain is less effective than electron transport via 
H2 cycling. The observation that Δfpo/Δfrh double mutants are incapable of 
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methylotrophic growth shows that additional electron transport routes are either 
not present, or not sufficient for methylotrophic growth (17). Mutants lacking Vht 
are inviable under all growth conditions, including methylotrophic growth, unless 
Frh is also removed. This phenotype is probably due the inability to recapture H2 
produced in the cytoplasm, which causes redox imbalance and cell lysis (18). 
Although the three M. barkeri hydrogenases have been studied in vitro 
and in certain mutants, a complete analysis of their role during growth on various 
substrates has yet to be reported. In this study, a previous graduate student in 
the Metcalf lab, Dr. Gargi Kulkarni, systematically deleted all five hydrogenase 
operons in all viable combinations. Together we examined the physiological 
ramifications of these mutations. Dr. Kulkarni measured growth and 
methanogenesis on various substrates, and I measured hydrogenase activity 
during growth on methanol. I also performed global transcriptional profiling to 
assess the possibility that alternate electron transport chain components might 
be upregulated to compensate for the loss of specific hydrogenases. The data 
suggest that hydrogenases are not required for methylotrophic methanogenesis, 
but are essential for CO2 reductive, methyl reductive, and aceticlastic 
methanogenesis. Additionally, an inhibitory effect of H2 on the methyl oxidative 
pathway appears to be mediated by all three hydrogenases. The results from this 
study have been published (22). 
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Figure 2.3. The branched electron transport systems of Methanosarcina 
barkeri and Methanosarcina acetivorans. During methylotrophic 
methanogenesis, M. barkeri can utilize H2-dependent or H2-independent electron 
transport systems. The H2-dependent pathway involves the use of hydrogenases 
Frh, Ech, and Vht in a H2 cycling mechanism to transfer electrons from F420red or 
Fdred to methanophenazine (MP). M. acetivorans does not utilize hydrogenases, 
and is therefore incapable of H2 cycling. Both organisms can conserve energy via 
a H2-independent pathway, wherein electrons are transferred from F420red to MP 
by way of the F420 dehydrogenase (Fpo). Additionally, the electron transport 
system in M. acetivorans includes the Na+-translocating Rnf enzyme complex 
that serves as a Fd:MP oxidoreductase. Both membrane-bound electron 
transport systems converge at the reduction of the CoM-S-S-CoB heterodisulfide  
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Figure 2.3. (continued) 
with electrons from reduced MPred via the cytochrome-containing HdrED enzyme. 
Protons (or Na+ in the case of Rnf) are translocated across the cell membrane in 
both systems, thereby conserving energy in the form of an ion motive force. An 
additional heterodisulfide reductase, HdrA1B1C1, has been proposed to function 
in the energy conservation pathways for both organisms. This electron bifurcating 
enzyme potentially reduces both the CoM-S-S-CoB heterodisulfide and F420 
with electrons from Fdred at a stoichiometric ratio of 2 Fdred oxidized for the 
reduction of 1 CoM-S-S-CoB to CoM-SH/CoB-SH and reduction of 1 F420ox to 
F420red. Abbreviations used are: Fdox/Fdred, oxidized and reduced ferredoxin; 
MP/MPH2, oxidized and reduced methanophenazine; F420ox/F420red, oxidized 
and reduced F420; CoM, coenzyme M; CoB, coenzyme B; CoM-S-S-CoB, 
heterodisulfide of CoM and CoB; FeS, iron-sulfur cluster; FAD, flavin adenine 
dinucleotide; FMN, flavin mononucleotide; NiFe, nickel-iron active site of 
hydrogenases; cytb1/cytb2/cyt c, cytochromes. 
 
Results 
Construction of hydrogenase deletion mutants  
To assess the role of the M. barkeri hydrogenases during growth on 
various substrates, Dr. Kulkarni constructed mutants lacking the frhADGB, 
freAEGB, vhtGACD, vhxGAC and echABCDEF operons, individually and in all 
possible combinations. Because mutants lacking vht are only viable in Δfrh 
mutants (18), she also created a series of conditional mutants that have the vht 
promoter replaced by the synthetic Ptet promoter, which is expressed in the 
presence of tetracycline and tightly repressed in its absence (12). To simplify the 
isolation of strains lacking the adjacent vht and vhx loci, a mutant allele was 
constructed (denoted Δvht-vhx) that deleted both operons along with two 
intervening genes that encode a putative peptidoglycan binding protein 
(Mbar_A1842) and an uncharacterized hypothetical protein (Mbar_A1843). The 
full set of strains containing deletions for hydrogenase operons in all possible 
 61 
combinations were successfully generated and verified by either Southern 
hybridization or PCR (Figures 2.6 - 2.9). 
 
Characterization of growth phenotypes in hydrogenase deletion mutants 
The generation time, growth yield and duration of lag phase for each 
mutant was determined by monitoring optical density during growth in a variety of 
media, providing clues as to the function of each hydrogenase during utilization 
of various carbon and energy sources (Table 2.1, Figure 2.4). With the exception 
of the Δfre and Δvhx mutations, which had no discernable phenotypes alone or in 
combination with other gene deletions, each of the mutations caused significant 
growth defects in one or more media.  
 Strains containing the Δech mutation were unable to grow in either H2-CO2 
or acetate media, regardless of whether the other hydrogenase genes were 
deleted. However, with the exception of the Ptetvht/Δech mutant discussed below, 
these mutants all grew on methanol medium, albeit with reduced growth rates. 
Consistent with previous reports (26), the Δech single mutant was unable to grow 
on unsupplemented methanol-H2-CO2 medium. Interestingly, the Δech/Δfrh 
double mutant regained the ability to grow in this medium, but with diminished 
rate and yield, and with the longest lag phase observed in any of our experiments. 
These phenotypes were substantially minimized in the Δech/Δfrh/Δvht triple 
mutant, suggesting that both Frh and Vht inhibit methanol oxidation, which is 
needed to provide reducing equivalents for biosynthesis, when H2 is present. 
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As previously reported, a mutant lacking only vht was not able to be 
obtained, suggesting that loss of this locus is lethal in otherwise wild-type strains 
(18). This conclusion was supported by the phenotype of the Ptetvht and 
Ptetvht/Δech mutants, which were incapable of growth on any medium when 
tetracycline is absent (i.e. under repressing conditions). However, as previously 
noted, when cells were grown on methanol it was possible to delete the vht 
operon if frh was deleted first. The Δfrh/Δvht strains, including ones that also 
carried an ech deletion, had methanol growth phenotypes similar to that of the 
wild type. Thus, hydrogenases are not required for growth on methanol, although 
vht-deficient strains are inviable in the presence of an active Frh hydrogenase. In 
contrast, strains lacking vht alone or in combination with other mutations were 
unable to grow on either H2-CO2 or acetate media. A more graded response was 
observed when various vht mutants were grown on methanol-H2-CO2. 
Accordingly, on this substrate combination, the vht single mutant was inviable, 
while the Δfrh/Δvht double mutant grew very poorly and the Δech/Δfrh/Δvht strain 
had phenotypes that were nearly wild-type. Again, these data are consistent with 
the idea that with certain mutant backgrounds Frh, Vht and Ech inhibit methanol 
oxidation in the presence of H2. 
Finally, mutants lacking only the frh operon grew on three out of four 
substrates tested, failing to grow only on H2-CO2 medium. When methanol was 
the sole substrate, the Δfrh mutant had an extended lag phase and a generation 
time approximately double that of the parental strain. However, during growth on 
either acetate or methanol-H2-CO2 the growth phenotypes of this strain were 
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equivalent to the parental strain, suggesting Frh enhances growth on methanol, 
but is not required for growth on the two latter substrate combinations. 
 
Figure 2.4. Growth of each hydrogenase mutant strain on four different 
types of substrate. The methanogenic pathways for growth on H2-CO2 (CO2 
reduction pathway; red arrows), methanol (methylotrophic pathway; light blue 
arrows), acetate (aceticlastic pathway; green arrows), and methanol-H2 (methyl  
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Figure 2.4. (continued) 
reductive pathway; dark blue arrows) are shown as depicted in Figure 2.2. For 
growth with acetate and methanol-H2, portions of the pathway that are not 
required for methanogenesis are shown in light grey. The steps catalyzed by Ech, 
Frh, and Vht hydrogenases are shown. A table indicating the ability of 
hydrogenase mutants to grow with each type of substrate is displayed next to 
each pathway. A green square indicates the presence of a hydrogenase, a red 
square indicates the absence of a hydrogenase, and (+) indicates growth of a 
strain. Abbreviations used are: Hdr, heterodisulfide reductase; MF, 
methanofuran; H4SPT, tetrahydrosarcinapterin; CoM, coenzyme M; CoB, 
coenzyme B; CoM-CoB, heterodisulfide of CoM and CoB; Fdox/Fdred, oxidized 
and reduced ferredoxin; F420ox/F420red, oxidized and reduced cofactor F420; 
MPox/MPred, oxidized and reduced methanophenazine. 
 
Methane and CO2 production by hydrogenase deletion mutants 
To probe the underlying mechanisms behind the growth phenotypes, Dr. 
Kulkarni also measured production of methane and CO2 by resting cell 
suspensions incubated with various substrates (Tables 2.2 & 2.3). The Ptetvht 
and Ptetvht/Δech mutants were not examined because they do not grow in any 
medium under non-inducing conditions. Similarly, production of methane from 
acetate was not assayed, because prior growth on acetate is required to induce 
the enzymes needed for this activity and most of the hydrogenase mutants are 
unable to grow under these conditions (14, 16). 
Consistent with their lack of growth phenotypes, the Δfre and Δvhx single 
mutations did not affect the levels of methane produced from any substrate 
tested. Neither did these mutations affect the ratio of methane/CO2 produced 
from methanol or from methanol-H2. However, the Δvhx mutation slowed the rate 
of methane production. The Δfre mutation also slowed the rate of methane 
production, but only when combined with the Δfrh mutation.  
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Table 2.3. Rate of CH4 productiona from resting cell 
suspensions of M. barkeri mutant strains. 
 
Genotype Methanol Methanol & H2 
Δhptb 86 ± 7 132 ± 18 
Δfre 84 ± 1 123 ± 16 
Δvhx 71 ± 2 74 ± 12 
Δech 57 ± 5 122 ± 7 
Δech/Δfrh 20 ± 1 27 ± 3 
Δech/Δfrh/Δvht 31 ± 2 30 ± 3 
Δech/Δfrh/Δfre/Δvht-vhxc 19 ± 2 19 ± 2 
Δfrh 23 ± 1 136 ± 9 
Δfrh/Δfre 14 ± 1 87 ± 3 
Δfrh/Δvht 38 ± 8 36 ± 4 
Δfrh/Δfre/Δvht-vhxc 32 ± 10 34 ± 13 
 
a nmol methane produced min-1 mg-1 
b M. barkeri Fusaro parental strain 
c Mbar_A1842 and Mbar_1843 also deleted 
 
As seen in previous studies, Δech mutants produced only minor amounts 
of methane from H2-CO2 (<2% relative to the parental strain), but produced wild-
type levels from both methanol and methanol-H2. During incubations with 
methanol, methane and CO2 were produced in a 3:1 ratio, consistent with 
disproportionation of the substrate via the methylotrophic pathway (Figure 2.2). 
Cell suspensions incubated with methanol and H2 produced only methane, 
showing that addition of hydrogen inhibits methanol oxidation. The rate of 
methane production by the Δech mutant was somewhat slower than wild-type 
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using both methanol and methanol-H2. This rate was further reduced when the 
ech deletion was combined with mutations removing the frh or vht operons. 
Accordingly, the Δech/Δfrh double mutant produced methane nearly 5 times 
slower than the wild-type strain.  Interestingly, this mutant produced a small 
amount of CO2 in addition to the wild-type level of methane, indicating a small 
amount of methanol was oxidized. When the ech, frh, and vht hydrogenases 
were deleted together, the quantity and stoichiometry of methane and CO2 
production was identical to that observed on methanol alone.  
The Δfrh single mutant produced similar levels and ratios of methane and 
CO2 relative to the parental strain with methanol or methanol-H2. When H2-CO2 
was the substrate, methane production was reduced ca. 10-fold, but, significantly, 
not abolished. Combining the Δfrh mutation with deletions of vht and ech reduced 
methane production from H2-CO2 to negligible levels. In contrast, minimal affects 
on methane and CO2 production or stoichiometry were observed when methanol 
was the sole substrate. However, when combined with deletions of vht or ech, 
the Δfrh mutants produced significant levels of CO2 when incubated with 
methanol-H2, and the triple Δech/Δfrh/Δvht mutant produced similar levels to that 
seen in assays incubated with methanol alone. Rates of methane production 
were substantially slower than wild-type for all Δfrh mutants. 
 
Enzyme activity in hydrogenase mutants  
I measured the hydrogenase activity for selected deletion mutants in the 
forward direction (H2 oxidation) to allow estimation of the contributions of each 
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enzyme to overall activity (Table 2.4). The hydrogenase activity of mutants 
lacking Fre or Vhx was not statistically different from the parental strain. 
Moreover, hydrogenase activity of the Δech/Δfrh/Δvht mutant, which still encodes 
Fre and Vhx, was not statistically different than the Δech/Δfrh/Δfre/Δvht-vhx 
mutant that lacks all five hydrogenase operons.  Thus, the freAEGB and vhxGAC 
operons do not, by themselves, produce detectable levels of hydrogenase. 
Because Fre and Vhx are essentially inactive, the hydrogenase levels in the 
Δfrh/Δvht and Δech/Δfrh strains can be attributed solely to Ech and Vht, 
respectively. Accordingly, Ech has the lowest activity of the three hydrogenases, 
accounting for ca. 4% of total activity, and with Vht activity being ca. 6-fold higher. 
Consistent with this conclusion, deletion of ech did not significantly affect 
hydrogenase activity, whereas the Δfrh strain had drastically diminished activity 
as compared to the parental strain. Additionally, activity from the Δfrh strain, 
which encodes both Vht and Ech, is roughly equivalent to the combined activities 
of strains encoding only Vht or only Ech. Because strains expressing only Frh 
hydrogenase are inviable, the activity of this hydrogenase cannot be directly 
determined from a mutant strain. However, the relative contribution of Frh can be 
estimated from the hydrogenase activities of other mutants. Thus, by subtracting 
the activities of Vht and Ech from that of the parental strain, we estimate that 
roughly 75% of hydrogenase activity can be attributed to Frh.  
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Table 2.4. Hydrogenase activity of M. barkeri mutant strains. 
 
Genotype Specific Activitya 
Δhptb 11.10 ± 4.29 
Δfre 9.18 ± 4.38 
Δvhx 8.51 ± 3.93 
Δech/Δfrh/Δvht 0.01 ± 0.00d 
Δech/Δfrh/Δfre/Δvht-vhxc 0.02 ± 0.00 
Δech 17.13 ± 4.90 
Δfrh/Δvht 0.42 ± 0.09 
Δech/Δfrh 2.60 ± 1.36 
Δfrh 3.12 ± 1.89 
          
a μmol H2 oxidized min-1 mg-1 
b M. barkeri Fusaro parental strain 
c Mbar_A1842 and Mbar_A1843 also deleted  
d values that are significantly different  (p-value < 0.01)  
than the Δhpt parental strain are indicated in bold. 
 
Effect of hydrogenase deletions on mRNA abundance  
The estimate of relative activities of the individual hydrogenases assumes 
that the expression levels for each hydrogenase are unaffected by deletion of the 
others. To explicitly examine this possibility, I determined the global mRNA 
abundance profiles for each mutant using RNA seq. Importantly, the RNA used in 
this analysis was isolated from the same cultures that were assayed for 
hydrogenase activity. The entire RNA seq dataset can be found under accession 
number GSE98441 at the Gene Expression Omnibus (GEO). A selection of 
results is presented in Tables 2.5 and 2.6. 
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As expected, the mRNA levels for the deleted genes in each mutant were 
significantly and substantially lower than the parental strain, providing an 
important validation that the correct strains were used in these assays. Moreover, 
no significant differences in mRNA abundance from the parent were observed for 
the remaining hydrogenases in any strain, showing that the expression of 
individual hydrogenase operons is not regulated by the presence/absence of 
other hydrogenase genes. Thus, the hydrogenase activities found in the various 
mutants accurately reflect the combined activities of each enzyme in all strains.  
 Large numbers of M. barkeri genes showed significant changes in mRNA 
abundance in the hydrogenase mutants, relative to the parental strain. 
Accordingly, 2.7% of all genes were differently regulated in strains with one or 
two deleted hydrogenases, whereas the Δech/Δfrh/Δvht and Δech/Δfrh/Δfre/Δvht-
vhx strains showed in 17.4% and 22.5% differently regulated genes, respectively. 
Of these, most encode proteins with unknown functions or with annotated 
functions that do not appear to be related to energy conservation. One exception 
was the F420 dehydrogenase (fpo), whose mRNA abundance increased 
significantly in all strains lacking frh (Table 2.6). This result suggests that the cell 
has a mechanism to sense the redox state of F420, which is altered upon 
deletion of frh.   
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Discussion 
While fully consistent with the proposed functions of the M. barkeri 
hydrogenases, our phenotypic characterization of mutants lends new insight into 
the flexibility and interconnected nature of methanogenic metabolism. For 
example, reduction of CO2 to CH4 is expected to require three kinds of electron 
donors: Fdred, F420red, and reduced methanophenazine (36). Consistent with this 
idea, mutants lacking hydrogenases that reduce Fd (Ech), F420 (Frh) or 
methanophenazine (Vht) are unable to grow on H2-CO2 (Table 2.1, Figure 2.4). 
Thus, it was surprising to observe production of methane from H2-CO2 in cell 
suspensions of Δfrh mutants. Assuming this process involves the standard CO2 
reduction pathway, this would require an alternative source of F420red for 
reduction of methenyl- and methylene-tetrahydrosarcinapterin (Figure 2.2). Two 
alternative sources can be envisioned: first, Fpo could produce F420red [standard 
reduction potential (E°’) = -360 mV] using reduced methanophenazine (E°’ = -165 
mV) as the electron donor via reverse electron transport driven by proton motive 
force; second, a soluble heterodisulfide reductase could produce F420red via 
electron bifurcation using CoM-S-S-CoB and Fdred as substrates (as suggested in 
(6, 44)). In the former mechanism, reduced methanophenazine would be derived 
from H2 using Vht; in the latter, Fdred would be derived from H2 via Ech. 
Interestingly, double mutants lacking Frh and either Ech or Vht produce much 
less methane than the Δfrh single mutant, thus both alternate pathways may 
contribute to this phenotype. The inability of the Δfrh mutant to grow on H2-CO2 
suggests that this alternate methane-producing pathway does not provide 
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sufficient energy for growth, or that it fails to provide an essential biosynthetic 
precursor.  
Similar metabolic flexibility is seen during methylotrophic methanogenesis, 
which can occur via H2-dependent or -independent mechanisms (Figures 2.2 & 
2.3) (17, 18, 25, 26). It was previously shown that a hydrogen cycling mechanism 
involving Frh and Vht is the preferred mode of electron transport in M. barkeri. 
Nevertheless, M. barkeri is also capable of methylotrophic growth in the absence 
of Frh and Vht (17, 18). Data reported in this chapter reveal that methylotrophic 
growth in M. barkeri is possible when all three hydrogenases are deleted (Table 
2.1, Figure 2.4).  Thus, an M. barkeri strain was created that is similar to 
Methanosarcina acetivorans, which has no detectable hydrogenase activity, but 
which grows well on methylotrophic substrates (11, 13). During methylotrophic 
growth in M. acetivorans, an electron transport chain comprised of Fpo and 
HdrED is used to capture energy from F420red produced by the oxidative branch 
of the methanogenic pathway (Figures 2.2 & 2.3). Prior genetic analyses suggest 
that Fpo is also used to metabolize F420red in M. barkeri Δfrh/Δvht mutants (17, 
18). The oxidative branch of the methylotrophic pathway also produces Fdred, 
which in M. acetivorans is oxidized by membrane-bound, ion-pumping 
Fdred:methanophenazine oxidoreductase known as Rnf (19).  However, because 
M. barkeri does not encode Rnf, this energy-conserving electron transport 
pathway in not available to the Ech mutants characterized here. Thus, an 
alternative Fdred:heterodisulfide oxidoreductase system must exist to allow 
growth of these mutants on methanol. It has been suggested that this alternate 
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Fdred:heterodisulfide oxidoreductase activity is catalyzed by a cytoplasmic, 
electron-bifurcating heterodisulfide reductase (HdrABC), similar to the electron-
bifurcating heterodisulfide reductase of non-cytochrome containing methanogens 
(Figure 2.3) (6). Biochemical data from a homologous M. acetivorans enzyme 
supports this possibility (44).  
Interestingly, the stoichiometry of methane and CO2 produced from 
methanol-H2 in ∆frh/∆vht and ∆frh/∆fre/Δvht-vhx mutants lends additional support 
for an alternate Fdred:heterodisulfide oxidoreductase. These strains, which 
encode only Ech, might be expected to disproportionate methanol to CH4 and 
CO2 in a 3:1 ratio, as was seen in the strains lacking all three active 
hydrogenases. Instead, they produced CH4 and CO2 at an approximate ratio of 
10:1, suggesting that a substantial portion of methanol was reduced directly to 
CH4 using electrons obtained by H2 oxidation. Because Ech is the sole remaining 
hydrogenase in these strains, electrons from Fdred must be involved in this 
process.  
H2 also inhibits oxidation of methanol when both substrates are present, 
via a mechanism that is clearly mediated by hydrogenase activity. Accordingly, in 
the presence of H2, methanol is solely reduced to methane by cell suspensions 
of strains that contain all three hydrogenases, while it is disproportionated to 
methane and CO2 in a 3:1 ratio when all three are absent. The hydrogenase-
mediated inhibition of methanol oxidation is graded, with Vht having the largest 
effect and Ech the least. Similarly, Ech mutants are only able to grow on 
methanol-H2 when supplemented with acetate and pyruvate, which has been 
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interpreted to mean they cannot produce the reducing equivalents needed for 
biosynthesis by oxidizing methanol to CO2 (26). In this chapter, it was shown that 
this effect is alleviated by deletion of genes encoding Frh and Vht, with the Δvht 
mutation having a much larger effect. Because protein synthesis was blocked by 
addition of puromycin in the cell suspension experiments, these effects cannot 
have been mediated by changes in the concentration of enzymes in the 
methanogenic pathways. Moreover, because inhibition requires the hydrogenase 
enzymes to be present, it is likely that a product of the enzymatic reaction 
mediates inhibition: namely the reduced enzyme cofactors. Thus, in the presence 
of high H2 partial pressures and the appropriate hydrogenase, we would expect 
the levels of oxidized methanophenazine, F420ox and Fdox to be kept at very low 
levels. Interestingly, the graded inhibition in response to loss of Vht, Frh, and Ech 
mimics the thermodynamics of the hydrogenase reactions, with 
methanophenazine being the most energetically favorable electron acceptor and 
Fd being the least. This suggests at least two possible mechanisms that might 
account for the inhibition: i) allosteric inhibition or covalent inactivation of a key 
enzymatic step in the oxidative branch of the pathway could be triggered by one 
or more reduced cofactors, or ii) simple changes in the availability of F420ox and 
Fdox, which are needed for three discrete steps in the oxidative branch of the 
methyloptrophic pathway (Figure 2.2). Note that in the second mechanism, the 
major inhibitory effect of Vht on methyl oxidation can only be explained if high 
levels of reduced methanophenazine influence the levels of F420ox, which could 
occur by changing the equilibrium of the Fpo reaction (Figures 2.2 & 2.3).  
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In addition to affecting flux through methanogenic pathways, the levels of 
reduced or oxidized cofactors may be used as a sensory input to modulate gene 
regulation. Transcriptional profiling of hydrogenase mutants showed that in all 
strains lacking frh, the fpo operon was significantly up-regulated. Without Frh, 
Fpo is solely responsible for the F420red:methanophenazine oxidoreductase 
activity required to transfer electrons from the oxidative to reductive portions of 
the methylotrophic electron transport pathway. Elevated abundance of fpo mRNA 
in Δfrh strains indicates that the cell has a mechanism to sense and respond to 
F420 redox imbalance. A previous study identified MreA as a global regulator in 
Methanosarcina with the ability to bind and repress the fpo promoter region 
during aceticlastic growth (31). This regulator was shown to affect gene 
expression based on growth substrate, however the mechanism and sensory 
input are unknown. Systems for gene regulation based on detected redox 
imbalance of F420 and other electron carriers are potential subjects for future 
studies. 
The levels of hydrogenase activity for the three enzyme types have 
significant ramifications for the hydrogen cycling model of energy conservation. 
In a previous study it was shown that Δvht mutations are lethal when Frh is 
present, but not when it is absent (18). Moreover, when vht expression is turned 
off using a regulated promoter, cell lysis is concomitant with H2 accumulation, 
implying that the inability to recapture H2 produced in the cytoplasm is 
responsible for the lethal phenotype.  With this in mind, it seems clear that the 
cytoplasmic activities of Frh must be carefully balanced against the external 
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activity of Vht. Interestingly, my data show that Frh activity is ca. 3-fold higher 
than that of Vht. Thus, it appears that ability of Frh to produce H2 is much higher 
than the ability of Vht to take it up. I recognize that our assays were not 
conducted with the native substrates (which are not commercially available); 
therefore, I approximated the in vivo activity of each enzyme based on available 
literature values in which a variety of natural and artificial cofactors were used 
(Table 2.7).  These data suggest that the relative activities of Frh and Vht are 
more similar than the assay data suggest, with Frh activity ca. 1.5-fold higher 
than Vht. While this extrapolation must be interpreted with caution, it still 
suggests that Frh capacity is higher than that of Vht. In this regard, both Vht and 
Ech are coupled to ion-motive force; thus, activity in whole, metabolically active 
cells could be substantially different.   
Finally, unlike Frh and Vht, Fre and Vhx are not able to provide sufficient 
levels of F420red and reduced methanophenazine, respectively, for growth via 
CO2 reduction. Additionally, the Δech/Δfrh/Δvht strain that only encoded for the 
Fre and Vhx hydrogenases had no detectable hydrogenase activity. This could 
be due to low expression of fre and vhx operons, absence of post-translational 
processing, mutations in structural or catalytic residues or some combination of 
these (13). Analysis of RNA sequencing data from wild type M. barkeri grown 
methylotrophically indicated the mRNA abundance for fre was approximately 50-
lower than frh, similar to the relative abundance observed by Vaupel and Thauer 
(39). Additionally, the abundance of vhx transcripts was more than 200-fold lower 
than those of vht.  I note that the enzymatic assays would have easily detected 
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hydrogenase activity at levels 200-fold lower than was observed for the strains 
encoding only vht. Thus, poor gene expression cannot explain the lack of activity 
in strains expressing only Fre of Vhx. Hydrogenases require several maturation 
steps to become active enzymes, including processing by the maturation 
proteases encoded by the frhD and vhtD genes. Thus, it remains possible that 
Fre and Vhx could encode active enzymes if FrhD and VhtD are trans-acting 
maturation proteases. Given that the mutants characterized here removed the 
entire frh and vht operons, these data do not address this possibility.  
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Materials and methods 
Media and growth conditions 
 Methanosarcina strains were grown as single cells (34) at 37 °C in high 
salt (HS) broth medium (23) or on agar-solidified medium as described (3). 
Growth substrates provided were methanol (125 mM in broth medium and 50 
mM in agar-solidified medium) or sodium acetate (120 mM) under a headspace 
of N2:CO2 (80:20 v/v) at 50 kPa over ambient pressure, H2:CO2 (80:20 v/v) at 300 
kPa over ambient pressure, or a combination of methanol plus hydrogen. 
Cultures were supplemented as indicated with 0.1% yeast extract (YE), 0.1% 
casamino acids (CAA), 10 mM sodium acetate, 10 mM pyruvate or 100 mM 
pyruvate. Puromycin (CalBioChem, San Diego, CA) was added at 2 μg ml-1 for 
selection of the puromycin transacetylase (pac) gene (30). 8-Aza-2,6-
diaminopurine (8-ADP) (Sigma, St Louis, MO) was added at 20 μg ml-1 for 
selection against the presence of hpt (30). Tetracycline (tet) was added at 100 μg 
ml-1 to induce the tetracycline-regulated PmcrB(tetO1) promoter (12). Standard 
conditions were used for growth of Escherichia coli strains (41) DH5α/λ-pir (28) 
and DH10B (Stratagene, La Jolla, CA), which were used as hosts for plasmid 
constructions. 
 
DNA methods and plasmid constructions 
Standard methods were used for plasmid DNA isolation and manipulation 
in E. coli (1). Liposome mediated transformation was used for Methanosarcina as 
described (24). Genomic DNA isolation and DNA hybridization were as described 
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(3, 23, 45). DNA sequences were determined from double-stranded templates by 
the W.M. Keck Center for comparative and functional genomics, University of 
Illinois. Plasmid constructions are described in Tables 2.8 and 2.9. 
 
Table 2.8. Plasmids used in this study. 
 
Plasmid Description and/or construction Reference 
pAMG77 
Plasmid containing a pac-hpt cassette and 
echABCDEF downstream region. (9) 
pAMG80 echABCDEF downstream region from PstI/SpeI-digested pAMG77 ligated to NsiI/AvrII-digested pMP44. This study 
pCGR10 
echABCDEF upstream region amplified using primers 
echupfor and echuprev, AscI/NotI-digested, and ligated 
to MluI/NotI-digested pAMG80. 
This study 
pGK6 
Plasmid containing a pac-hpt cassette and freAEGB 
upstream/downstream homology regions. Used to 
delete freAEGB from M. barkeri Fusaro chromosome 
using the markerless exchange method.  
(17) 
pGK7 
vhxGAC upstream and downstream regions amplified 
using primers vh3upfor, vh3uprev, vh3dnfor and 
vh3dnrev, fused with fusion PCR, AscI/NotI-digested, 
and ligated to MluI/NotI-digested pMP44. 
This study 
pGK8 
echABCDEF upstream region amplified using primers 
echdoubleupfor and echdoubleuprev, NotI/BamHI-
digested, and ligated to NotI/BamHI-digested pJK301. 
This study 
pGK9 
echABCDEF downstream region amplified using 
primers echdoublednfor and echdoublednrev, 
XhoI/ApaI-digested, and ligated to XhoI/ApaI-digested 
pGK8. 
This study 
pGK11 
vhxGAC downstream region amplified using primers 
vhxdnfor1 and vh3dnrev, SpeI/NotI-digested, and 
ligated to 6.7 kb fragment of SpeI/NotI-digested 
pGK82B. 
This study 
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Table 2.8. (continued) 
 
Plasmid Description and/or construction Reference 
pGK61A 
Plasmid containing a pac-hpt cassette flanked by FRT5 
sites and PmcrB-tetR. Used to exchange the vhtGACD 
native promoter with the PmcrB(tetO3) tet-regulated 
promoter. 
(18) 
pGK82B 
Plasmid containing a pac-hpt cassette and vhtGACD 
upstream/downstream homology regions. Used to 
delete vhtGACD from M. barkeri Fusaro chromosome 
using the double homologous recombination-mediated 
gene replacement method. 
(18) 
pJK301 
Vector containing a pac-hpt cassette. Used to delete 
genes from M. barkeri Fusaro chromosome using 
double homologous recombination-mediated gene 
replacement. 
(42) 
pMP44 
Vector containing a pac-hpt cassette. Used to delete 
genes from M. barkeri Fusaro chromosome using the 
markerless exchange method. 
(30) 
pMR55 Non-replicating plasmid that contains the Flp recombinase gene under control of the mcrB promoter. (33) 
 
Strain construction in M. barkeri 
The construction and genotype of all Methanosarcina strains is presented 
in Table 2.10. Hydrogenase encoding genes were deleted sequentially in a 
specific order (Figure 2.5) because certain hydrogenase deletion mutants are 
only viable when other hydrogenase genes are deleted first (18). To simplify 
isolation of strains that lack hydrogenase operons vhxGAC and vhtGACD, the 
genes between the two operons (Mbar_A1842 and Mbar_A1843) were also 
deleted (Figure 2.1). All mutants were confirmed by either PCR or DNA 
hybridization (Figures 2.6 - 2.9).  
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Table 2.9. Primers used in this study. 
 
Primer Sequencea 
echupfor GGCGCGCCTCAATGGATTGCAGACCAAA 
echuprev GGCGCGCCGCGGCCGCCCCGGGTATCCTCCGATCTAT-TAATCC 
vh3upfor GGCGCGCCCCGTGAGGTGACAGGAGTTT 
vh3uprev TTCTTCTTCGAACTTCCCCATTTGCAACAGTAGGAGATT-GTTT 
vh3dnfor AAACAATCTCCTACTGTTGCAAATGGGGAAGTTCGAAG-AAGAA 
vh3dnrev GGCGCGCCGCGGCCGCGCTTGGAAGCTGTTTTGGAG 
echdoubleupfor GGCGCGCCGCGGCCGCGTGTTCATCCGTTCCGATTT 
echdoubleuprev GGCGCGCCGGATCCACAGCGTATCCTCCGATCTA 
echdoublednfor GGCGCGCCCTCGAGAGACAAGCCAAAAGCTCCAA 
echdoublednrev GGCGCGCCGGGCCCACATACTCTGCCGCATACCC 
vhxdnfor1 GGCGCGCCACTAGTTGATAACAAGCGCAGATATTATTTA 
frhfor5 AAATTCGGGAGGAGATGTTAGAG 
frhrev6 CAGAACCCTGCTTTCTAAGAATG 
16SFor ATTCTGGTTGATCCTGCCAGAGGTTAC 
T716SRev 
GCCGGGAATTTAATACGACTCACTATAGGGGGTCAGG-
TTCGAACACGGCACG 
23SFor CAAACGTCTGGCGGTAAAAT 
T723SRev 
GCCGGGAATTTAATACGACTCACTATAGGGCCTATCG-
GGGTCCTCTTCTC 
 
a Introduced restriction endonuclease recognition sequences are single 
underlined. Double underline indicates introduced overlap region for fusion PCR. 
b T7 promoter region is emboldened. 
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Table 2.10. M. barkeri Fusaro strains used in this study. 
 
Strain Genotype Source or Construction 
WWM85 ∆hpt::PmcrB-IC31-int-attP M. barkeri Fusaro parental strain. (12) 
WWM115 
∆frhADGB, 
∆hpt::PmcrB-IC31-int-attB (18) 
WWM116 
∆freAEGB, 
∆hpt::PmcrB-IC31-int-attP (17) 
WWM133 
∆echABCDEF,  
∆hpt::PmcrB-IC31-int-attP 
Deletion of echABCDEF in 
WWM85 with pCGR10. 
WWM157 
PmcrB(tetO3)::vhtGACD, 
PmcrB-tetR-pac-hpt,a 
∆hpt::PmcrB-tetR-IC31-int-attB 
(18) 
WWM234 
∆freAEGB, ∆frhADGB, 
∆hpt::PmcrB-IC31-int-attB 
Deletion of freAEGB in WWM115 
with pGK6. 
WWM237 
∆vhxGAC,  
∆hpt::PmcrB-IC31-int-attP 
Deletion of vhxGAC in WWM85 
with pGK7. 
WWM327 
∆vhtGACD, ∆Mbar_A1843, 
∆Mbar_A1842, ∆vhxGAC, 
∆freAEGB, ∆frhADGB, 
∆hpt::PmcrB-IC31-int-attB 
Deletion of vht-vhx in WWM234 
with XhoI/NotI-digested 5.6 kb 
pGK11 and removal of pac-hpt 
cassette using pMR55. 
WWM351 
∆vhtGACD::FRT, ∆frhADGB, 
∆hpt::PmcrB-IC31-int-attB (18) 
WWM363 
PmcrB(tetO3)::vhtGACD, 
PmcrB-tetR-pac-hpt,a 
∆echABCDEF,  
∆hpt::PmcrB-IC31-int-attP 
Exchange of vhtGACD native 
promoter with tet-regulated 
promoter in WWM133 using 
NcoI/SpeI-digested 7.0 kb 
pGK61A. 
WWM366 
∆echABCDEF::pac-hpt, 
∆vhtGACD::FRT, ∆frhADGB, 
∆hpt::PmcrB-IC31-int-attB 
Deletion of echABCDEF in 
WWM351 with ApaI/NotI-digested 
5.6 kb pGK9. 
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Table 2.10. (continued) 
 
Strain Genotype Source or Construction 
WWM369 
∆echABCDEF::pac-hpt, 
∆vhtGACD::FRT, ∆frhADGB, 
∆hpt::PmcrB-IC31-int-attB 
Deletion of echABCDEF in 
WWM351 with ApaI/NotI-digested 
5.6 kb pGK9. Sibling of 
WWM366. 
WWM370 
∆echABCDEF::pac-hpt, 
∆frhADGB,  
∆hpt::PmcrB-IC31-int-attB 
Deletion of echABCDEF in 
WWM115 with ApaI/NotI-digested 
5.6 kb pGK9. 
WWM388 
∆echABCDEF::pac-hpt, 
∆vhtGACD, ∆Mbar_A1843, 
∆Mbar_A1842, ∆vhxGAC, 
∆freAEGB, ∆frhADGB, 
∆hpt::PmcrB-IC31-int-attB 
Deletion of echABCDEF in 
WWM327 with ApaI/NotI-digested 
5.6 kb pGK9. 
WWM570 
∆echABCDEF::FRT, 
∆vhtGACD::FRT, ∆frhADGB, 
∆hpt::PmcrB-IC31-int-attB 
Removal of pac-hpt cassette in 
WWM369 using pMR55. 
 
a The promoter replacement cassette from pGK61A (Table 2.8) includes a copy 
of tetR under control of the strong PmcrB promoter (PmcrB-tetR-pac-hpt) to 
ensure tight repression of the PmcrB(tetO3) promoter in the absence of 
tetracycline (18). 
 
Determination of growth characteristics 
For growth rate determinations, cultures were grown on methanol or 
methanol plus H2-CO2 (∆frh and ∆frh/∆fre) to mid-log phase (optical density at 
600 nm [OD600] ca. 0.5). Approximately 3% inoculum of the culture (or 10%, in 
case of acetate) was then transferred to fresh medium in at least four replicates 
and incubated at 37 °C. Growth was quantified by measuring OD600. With the 
exception of samples grown on acetate, all OD600 were measured with a 
Spectronic 20 spectrophotometer (Thermo Fisher Scientific, Waltham, MA); 
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those grown on acetate were measured with a Hewlett Packard 8453 
spectrophotometer (Agilent, Santa Clara, CA). Note that an OD of 1.0 on the 
Hewlett Packard 8453 is equivalent to an OD of ~0.2 on the Spectronic 20.  
Generation times were calculated during exponential growth phase and lag 
phase was defined as the time required to reach half-maximal OD600.   
 
 
Figure 2.5. Flowchart depicting isolation of a series of M. barkeri 
hydrogenase deletion mutants. The first row represents single hydrogenase 
deletion mutants, with strain names shown above the relevant genotype (blue 
boxes). These strains were used as the starting point for deletion of the 
echABCDEF, freAEGB, vhxGAC, or vhtGACD operons. Growth media used 
during mutant isolation are indicated. Mutants in red were isolated in this study 
and those in black were constructed in previous studies (for references and strain 
construction details see Table 2.10). The tetracycline (tet)-regulated conditional 
vhtGACD mutant is denoted as Ptetvht. The Δvht-vhx mutation simultaneously 
removes both operons, along with the Mbar_A1842 and Mbar_A1843 loci, which 
are encode between the two hydrogenase operons (see Figure 2.1). 
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Cell suspension experiments 
Cells grown on methanol or methanol plus H2-CO2 (∆frh and ∆frh/∆fre) 
were collected in late exponential phase (OD600 = 0.6-0.7) by centrifugation at 
5,000 x g for 15 minutes at 4 °C. The cells were washed once with anaerobic HS 
PIPES buffer (50 mM PIPES at pH 6.8, 400 mM NaCl, 13 mM KCl, 54 mM MgCl2, 
2 mM CaCl2, 2.8 mM cysteine, 0.4 mM Na2S) and resuspended in the same 
buffer to a final concentration of 109 cells/ml. Cells were counted visually using 
the Petroff-Hausser counting chamber (Hausser Scientific, PA). All assay 
mixtures contained 2 ml of the suspension and were conducted under strictly 
anaerobic conditions in 25 ml Balch tubes sealed with butyl rubber stoppers 
using 250 mM methanol as the methanogenic substrate under a headspace of N2, 
H2, or H2-CO2 (80/20%) at 250 kPa over the ambient pressure, as indicated. 
Puromycin (20 μg/ml) was added to prevent protein synthesis. Cells were held on 
ice until initiation of assay by transfer to 37 °C. For rate determination, gas phase 
samples were withdrawn at various time points and assayed for CH4 by gas 
chromatography at 225 °C in a Hewlett Packard gas chromatograph (5890 Series 
II) equipped with a flame ionization detector. The column used was stainless 
steel filled with 80/120 CarbopackTM B/3% SPTM-1500 (Supelco, Bellefonte, PA) 
with helium as the carrier gas. For total CH4 and CO2 production, assays were 
incubated at 37 °C for 36 hours prior to withdrawal of gas phase samples for 
analysis by GC at 225 °C in a Hewlett Packard gas chromatograph (5890 Series 
II) equipped with a thermal conductivity detector. A stainless steel 60/80 
Carboxen-1000 column (Supelco, Bellefonte, PA) with helium as the carrier gas 
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was used. Total cell protein was determined using the Bradford method (4) after 
1 ml of the cells was lysed by resuspension in ddH20 with 1 μg/ml RNase and 
DNase. 
 
Hydrogenase assays 
Strains were grown at 37 °C in HS medium supplemented with 125 mM 
methanol and cells were harvested from 10 ml mid-exponential phase culture at 
1228 x g for 15 min in an IEC MediSpin (Needham Heights, MA) benchtop 
centrifuge. Preparation of cell extract was performed in an anaerobic chamber 
under an atmosphere of H2/N2 (4/96%). Cells were washed once in 10 ml HS-
MOPS [2 mM dithiothreitol (DTT), 400 mM NaCl, 13 mM KCl, 54 mM MgCl2, 2 
mM CaCl2, 50 mM MOPS, pH 7.0] and lysed in 1 ml lysis buffer (2 mM DTT, 
0.5% n-dodecyl β-D-maltoside, ca. 50 Kunitz units bovine pancreas 
deoxyribonuclease I, 50 mM MOPS, pH 7.0) on ice for 30 min. Enzyme-
containing supernatant was separated from cell debris by centrifugation at 13600 
x g for 2.5 min (Fisher Scientific Micro Centrifuge Model 235C, Waltham, MA). 
Protein concentration was measured via the Bradford method (4). 
 Assays were performed anaerobically in 1.7 ml quartz cuvettes sealed 
with rubber stoppers. A total reaction volume of 1 ml was used, and included cell 
extract mixed with 50 mM MOPS buffer (pH 7.0) containing 2 mM DTT and 2 mM 
benzyl viologen (BV). The cuvette headspace was pressurized to 30 kPa with 
100% H2 after being flushed for 2 min. Cuvettes with reaction mixture were pre-
warmed to 30 °C before the reaction was initiated by the addition of BV. 
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Hydrogenase activity was determined by quantifying the change in absorbance of 
BV at 578 nm (extinction coefficient, 8.65 cm-1 mM-1) with a Cary 50 UV-Vis 
Spectrophotometer (Agilent, Santa Clara, CA). One unit (U) of hydrogenase 
activity was defined as the oxidation of 1 μmol H2 per minute, based on the fact 
that 2 μmol BV are reduced for each H2 oxidized. A minimum of three 
independent measurements from biological replicates was performed for each 
strain. 
 
RNA sequencing 
 Immediately prior to cell harvest for hydrogenase assays, 2.5 ml of the 
same culture was harvested for total RNA isolation. An equal volume of TRIzol 
reagent (Ambion, Carlsbad, CA) was added to the culture to lyse cells and 
samples were incubated at room temperature for 5 min. RNA was then isolated 
with a Direct-zol RNA MiniPrep kit from Zymo Research (Irvine, CA) according to 
the manufacturer’s directions. RNA samples were stored at -80 °C. 
 To increase coverage of mRNA during sequencing, rRNA was removed 
from samples via subtractive hybridization. The method of Stewart et al. (35) was 
utilized with the following modifications. Templates for 16S and 23S rRNA probes 
were generated by PCR from strain WWM85 with primers 16SFor, T716SRev, 
23SFor, and T723SRev (Table 2.9). In vitro transcription with the MEGAscript 
High Yield Transcription kit (Ambion) was used for the production of biotinylated 
antisense rRNA probes from 400 ng of the purified PCR products in separate 
reactions. After removal of template with DNAseI, probes were purified with the 
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Zymo Research RNA Clean & Concentrator kit. Hybridization reactions (30 μl) for 
each sample contained the following: 20% formamide, 1X SSC buffer, 20 U 
SUPERase inhibitor, 2 μg total RNA, 4 μg 16S probe, and 4 μg 23S probe. 
Reactions were denatured at 70 °C for 10 min, ramped down to 25 °C (-0.1 °C 
sec-1), and incubated at room temperature for 10 min. rRNA hybridized to 
biotinylated probe was removed via streptavidin-coated magnetic beads (New 
England Biolabs, Ipswich, MA). Beads (500 μl per sample) were washed twice 
with 500 μl 1X SSC buffer prior to the addition of hybridized RNA sample diluted 
to 250 μl in 1X SSC buffer with 20% formamide. Samples were incubated for 1 
hour at room temperature with gentle shaking before separation of beads on a 
magnetic rack. The supernatant was removed, beads were washed with 250 μl 
1X SSC, and supernatant and wash were pooled and cleaned with the Zymo 
Research RNA Clean & Concentrator kit. 
Preparation and sequencing of RNAseq libraries was performed at the 
Roy J. Carver Biotechnology Center at the University of Illinois at Urbana-
Champaign. Libraries were made with the TruSeq Stranded mRNA Sample Prep 
kit, sequenced with a HiSeq 2000 using the TruSeq SBS v3 kit, and processed 
with Casava 1.8.2, all per the manufacturer’s directions (Illumina, San Diego, CA). 
All sequencing data was further processed and analyzed as previously described 
(10) with CLC Genomics Workbench 7 (Qiagen). Within this program, the 
Empirical analysis of Differential Gene Expression (EDGE) tool was used for 
statistical analysis (32). Differently regulated genes were considered significant 
when up- or down-regulated at least 3-fold with a p-value ≤ 0.05. Three biological 
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replicates were sequenced and analyzed for each strain. Raw and processed 
data have been deposited in the Gene Expression Omnibus (GEO) under the 
accession number GSE98441.  
 
 
 
Figure 2.6. Verification of ∆frh in WWM234 (∆frh/∆fre) by Southern 
hybridization. Predicted bands (kb): AseI: WWM85 (WT) = 5.6, WWM234 (M) = 
1.9; EcoRI: WT = 5.4, M = 2.8; HindIII: WT = 4.9 and 2.6, M = 2.6 and 1.3; XbaI: 
WT = 7.8, M = 4.1. MW:  DIG-labeled DNA molecular weight marker III (Roche, 
Indianapolis, IN). The probe was a 600 bp PCR product amplified from the 
frhADGB deletion plasmid pGK4 (18) with primers frhfor5 and frhrev6 (Table 2.8). 
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Figure 2.7. Verification of ∆vht-vhx in WWM327 (∆frh/∆fre/∆vht-vhx) by 
Southern hybridization. Predicted bands (kb): SstI: WWM85 (WT) = 9.2, 
WWM327 (M) = 1.5; AseI: WT = 4.5 and 1.0, M = 1.4 and 1.0; XmaI: WT = 20.9, 
M = 1.7; NdeI: WT = 10.8, M = 3.8. MW:  DIG-labeled DNA molecular weight 
marker III (Roche, Indianapolis, IN). The 639 bp and 754 bp fragments of EcoRI-
digested pGK12 (Table 2.8) were used as probe. Lanes not belonging to these 
strains have been cropped from the image. 
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Figure 2.8. Verification of ∆ech in WWM370 [∆ech/∆frh (#1 and #2)] and 
WWM369 [∆ech/∆frh/∆vht (#3 and #4)] by Southern hybridization. Predicted 
bands (kb): EcoRV: WWM85 (WT) = 3.6, WWM370 and WWM369 (#1, #2, #3, 
#4) = 5.9; HindIII: WT = 4.5, (#1, #2, #3, #4) = 0.5; PstI: WT = 9.2, (#1, #2, #3, 
#4) = 4.2. MW:  DIG-labeled DNA molecular weight marker III (Roche, 
Indianapolis, IN). The 450 bp fragment of HindIII-digested pGK9 (Table 2.8) was 
used as probe. 
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Figure 2.9. Verification of ∆ech in WWM388 (∆ech/∆frh/∆fre/∆vht-vhx) by 
Southern hybridization. Predicted bands (kb): EcoRV: WWM85 (WT) = 3.6, 
WWM388 (M) = 5.9; HindIII: WT = 4.5, M = 0.5; PstI: WT = 9.2, M = 4.2. MW:  
DIG-labeled DNA molecular weight marker III (Roche, Indianapolis, IN). The 450 
bp fragment of HindIII-digested pGK9 (Table 2.8) was used as probe. 
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Chapter 3: Hydrogenase inactivation in the methanogenic archaeon 
Methanosarcina acetivorans via regulation at the transcriptional, 
translational, and enzyme maturation levels 
 
Methanosarcina acetivorans cannot use H2 as a substrate for 
methanogenesis and is completely devoid of hydrogenase activity. Nevertheless, 
this organism encodes FrhAGB and VhtGAC hydrogenases with 72-93% identity 
to the active hydrogenases found in Methanosarcina barkeri. Moreover, 
heterologous expression of Vht from M. acetivorans (Ma_Vht) in an M. barkeri 
hydrogenase deficient mutant allowed production of an enzyme with 
hydrogenase activity approximately equivalent to that of Vht from M. barkeri 
(Mb_Vht). To understand how hydrogenases are regulated in M. acetivorans, 
mRNA abundance, protein production, and hydrogenase activity were measured 
in a set of M. acetivorans and M. barkeri strains that heterologously express the 
Ma_vht or Mb_vht operons with native or inducible promoters. When transcribed 
from native promoters in M. acetivorans, Mb_vht and Ma_vht transcript levels 
were equally abundant, yet ca. 20-fold lower than the level of Mb_vht when 
transcribed from the native M. barkeri promoter. Similar results were obtained 
when Ma_vht and Mb_vht were transcribed from inducible promoters in M. 
acetivorans, suggesting regulation of transcription that is independent of 
promoter recognition. Despite transcription of Ma_vht in M. acetivorans, the 
protein was not detected via immunoblotting. However, high transcript levels of 
Ma_vht or Mb_vht from inducible promoters in M. acetivorans led to detectable 
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amounts of hydrogenase protein. Despite this, functional hydrogenases were not 
produced in any of the M. acetivorans strains, which was most likely due to an 
inability to process the apoenzyme into the active form. These data suggest that 
synthesis of active Vht hydrogenase in M. acetivorans is actively suppressed by 
regulation at the transcriptional, translational, and protein maturation levels. 
 
Importance 
Methanogenesis, the biological process of methane production, is a form 
of metabolism that is unique to a class of archaea known as the methanogens. 
These organisms make possible the conversion of organic substrates into 
methane and CO2, and therefore have an impact on everything from agriculture 
and waste management, to energy production and human health. Thus, 
elucidating the regulation of enzymes critical to methanogenesis, as we have 
done with this study, has wide-ranging effects. Additionally, the data presented 
here broadens our understanding of gene regulation in archaea, for which much 
less is known than for bacteria and eukaryotes. 
 
Introduction 
 Methanogenic archaea (methanogens) play a critical role in the global 
carbon cycle by facilitating the terminal steps in conversion of organic carbon into 
methane and CO2 in environments lacking alternative electron acceptors. 
Methanogens belong to a large and diverse archaeal group, yet have in common 
the requirement to produce methane during energy conserving metabolism. A 
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small number of substrates can be used for methanogenesis, with nearly all 
species being restricted to the reduction of CO2 to methane with electrons 
derived from H2 or formate (31). However, members of the genus 
Methanosarcina have a broad substrate range that includes acetate and C1 
compounds (i.e. single-carbon compounds such as methanol, methylated amines, 
or dimethyl sulfide), in addition to H2-CO2. We previously showed that in addition 
to its use as a substrate for the reduction of CO2 to methane, H2 also serves as 
an electron-carrying intermediate during methanogenesis from other substrate 
types in Methanosarcina barkeri (16, 17, 22). Thus, consumption and production 
of H2 is a critical metabolic component for this, and other, methanogens. 
 Hydrogenases, which reversibly catalyze H2 oxidation, are a key enzyme 
for any organism that metabolizes H2. Methanosarcina species contain three 
different types of hydrogenase, all of which are characterized as [NiFe] 
hydrogenases based on the bimetallic cofactor found in their active sites (32). 
Enzymes from this class of hydrogenase are minimally composed of a large 
catalytic subunit that contains the [NiFe] active site, and a small electron-transfer 
subunit that contains linearly arranged iron-sulfur clusters that serve as a conduit 
for electrons moving to or from the active site (34). The [NiFe] cofactor of these 
enzymes is comprised of an iron moiety bridged to a nickel moiety by a pair of 
cysteine residues. Additionally, the Fe atom is coordinated by 1 CO and 2 CN- 
groups, and the Ni atom is coordinated by two additional cysteine residues (24). 
Post-translational conversion of the large subunit into the fully active 
holoenzymatic form requires synthesis and insertion of the [NiFe] cofactor into 
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the active site. This process is facilitated by the gene products of hypF and the 
hypCDABE operon (24, 28). For most [NiFe] hydrogenases, the final maturation 
step, in which a short C-terminal peptide is cleaved from the large subunit after 
the cofactor has been inserted, facilitates a conformational change that is 
required for hydrogenase activity (28). 
 The three types of hydrogenases utilized by Methanosarcina species 
include the ferredoxin-reducing, energy-converting hydrogenase (Ech), the 
soluble F420-reducing hydrogenase (Frh), and the membrane-bound 
methanophenazine-reducing hydrogenase (Vht) (11). All three hydrogenases are 
known to be active in M. barkeri, and required for growth with H2-CO2. 
Additionally, the enzymes can be used for efficient growth with methanol, 
although an alternative H2-independent mechanism can also be utilized with this 
substrate (16, 17). The operons encoding the hydrogenases from M. barkeri and 
M. acetivorans are depicted in Figure 3.1. Whereas the Ech hydrogenase is not 
encoded by M. acetivorans, the Frh and Vht hydrogenase are encoded by both 
species with a high level of amino acid sequence identity (72-93%). Additionally, 
all amino acid sequences essential to active site coordination are conserved in 
Frh and Vht from M. barkeri and M. acetivorans (11). Both organisms also 
encode a Vht homolog (Vhx), and M. barkeri encodes a Frh homolog (Fre) (11, 
33). However, strains of M. barkeri that only contain Vhx or Fre have no 
detectable hydrogenase activity and are unable to grow with H2-CO2. Therefore, 
these homologs are thought to be inactive (17). 
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Figure 3.1. Hydrogenase operons of M. barkeri and M. acetivorans. The 
methanophenazine reducing hydrogenase (vhtGACD) and F420 reducing 
hydrogenase (frhADGB) operons from M. barkeri and M. acetivorans share a 
high level of amino acid sequence identity (AA Ident.) between the strains. M. 
barkeri also contains an energy converting hydrogenase (echABCDEF) that is 
not present in the genome of M. acetivorans. Locus tags are shown below each 
gene; due to space constraints, an * replaces “Mbar_” for some genes. 
 
 Despite encoding hydrogenases with a high level of similarity to enzymes 
that are known to be active, M. acetivorans is unable to grow with H2-CO2 as the 
sole source of carbon and energy, and is devoid of hydrogenase activity during 
growth with methanol or methanol-H2-CO2 (9). Prior analysis of hydrogenase 
expression via translational fusions to a reporter gene suggested that Frh and 
Vht from M. acetivorans are inactive due to nonfunctional promoters (11). 
However, the ability to produce an active protein from these gene products was 
not tested. In this chapter, I describe investigations into whether the M. 
acetivorans encoded Vht can produce an active hydrogenase when expressed in 
a host known to have robust hydrogenase activity, M. barkeri. Remarkably, I 
found it to be a fully functional enzyme, which led me to take a closer look at 
mechanisms of hydrogenase inactivation in M. acetivorans. By measuring 
transcript abundance, protein production, and hydrogenase activity of Vht in both 
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M. barkeri and M. acetivorans, I determined that regulation occurs at the 
transcriptional, translational, and post-translational levels. 
 
Results 
Vht hydrogenase activity in M. acetivorans and M. barkeri  
I used a genetic approach to investigate the paradoxical presence of 
hydrogenase genes in M. acetivorans, a host that is devoid of hydrogenase 
activity. The approach involved heterologous expression of the genes encoding 
the putative Vht hydrogenase from M. acetivorans (Ma_vht) in M. barkeri, a host 
that is known to produce functional hydrogenases. To clearly distinguish between 
native and recombinant hydrogenases, I employed an M. barkeri Δvht Δfrh Δech 
triple mutant strain (M. barkeri Δhyd), for these experiments. For a complement 
to these experiments, I also attempted to express the Vht hydrogenase from M. 
barkeri (Mb_vht) in M. acetivorans. In both cases, the recombinant genes, along 
with appropriate controls, were inserted into the chromosome of the heterologous 
host in single copy via site-specific recombination. Production of functional 
enzymes in each strain was then established by quantitative hydrogenase activity 
assays (Figure 3.2).  
Initial control experiments were conducted to establish baseline activity 
levels. Consistent with prior findings (9, 17), hydrogenase activity was not 
detected in extracts of M. acetivorans or M. barkeri Δhyd, but substantial activity 
could be detected from wild type M. barkeri. Moreover, expression of Mb_vht in 
M. barkeri Δhyd led to the same level of activity as the M. barkeri Δech Δfrh 
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strain (which contains Vht as the only active hydrogenase). Thus, expression of 
the recombinant genes was not significantly affected by their localization to an 
ectopic site distal to the native vht locus. 
 
 
Figure 3.2. Hydrogenase enzyme activity of Methanosarcina strains. 
Hydrogenase activity (U/mg) was measured from cell-free lysate of M. 
acetivorans (M.acet.) and M. barkeri (M.bar.) strains, including wild-type strains 
(WT), and M. barkeri mutants lacking all hydrogenases (Δhyd) or lacking the ech 
and frh hydrogenases (Δech, Δfrh). Whereas substantial hydrogenase activity 
was measured for M. barkeri (WT), activity from M. acetivorans (WT) was not 
detected (ND). M. barkeri Δhyd also had no detectable activity, unless 
supplemented with the vht operons from M. barkeri (Mb_vht) or M. acetivorans 
(Ma_vht) that were expressed from the native promoter or a tetracycline-
inducible promoter (PtetMb_vht & PtetMa_vht). In M. barkeri Δhyd under inducing 
conditions (+ tetracycline), activity was detected from both the M. acetivorans 
and M. barkeri versions of Vht. Hydrogenase activity was not detected in any M. 
acetivorans strain under any condition. 
 
The lack of hydrogenase activity in M. acetivorans could be due to subtle 
changes within the coding sequences that result in non-functional proteins, or 
due to deficiencies in the host’s ability to express the proteins and/or to convert 
the apoenzymes into the fully active holoenzymes. To distinguish between these 
possibilities, I expressed the Ma_vht operon in M. barkeri Δhyd. Previous studies 
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suggested that the Ma_vht promoter is not active in M. barkeri (11). Therefore, I 
placed the operon under control of the strong, tetracycline-inducible promoter 
(Ptet) in this strain (referred to as PtetMa_vht). As a control, I constructed a similar 
strain that expressed the Mb_vht operon from the same promoter (PtetMb_vht). 
When expression was induced by addition of tetracycline, both strains had similar 
hydrogenase activities (Figure 3.2). 
The activity of Ma_vht in M. barkeri suggests that the lack of hydrogenase 
activity in wild-type M. acetivorans is due to the host rather than the coding 
sequence of the genes. To test this idea, we conducted a complementary 
experiment in which Mb_vht was expressed from its native promoter in M. 
acetivorans. Extracts from this strain were devoid of hydrogenase activity, 
supporting the idea that M. acetivorans is incapable of expressing a functional 
hydrogenase. Previous reporter gene studies showed that the Mb_vht native 
promoter is active in M. acetivorans (11). Thus, it seems unlikely that the 
absence of hydrogenase activity in the M. acetivorans strain carrying Mb_vht was 
due to poor transcription. To rule out this possibility, we constructed a strain 
carrying Mb_vht under control of Ptet, which is known to be highly active in M. 
acetivorans (10). As a control, we constructed a similar strain in which the native 
Ma_vht operon was placed under control of the same promoter (note that this 
strain retains the endogenous copy of vht under control of its native promoter). 
Neither strain produced detectable hydrogenase activity. Thus, the lack of 
hydrogenase activity in M. acetivorans is not due to a promoter defect. 
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 Abundance of Ma_vht and Mb_vht mRNA in M. acetivorans versus M. barkeri  
Although promoter activity does not seem to be responsible for the lack of 
hydrogenase activity, it is possible that hydrogenase transcripts are unstable in M. 
acetivorans. To test this, we quantified vht message RNA (mRNA) abundance 
with qRT-PCR using RNA polymerase (rpoA1) transcript abundance to normalize 
the data. A single set of primers was designed to amplify rpoA1 from a 
homologous region in M. barkeri and M. acetivorans, and separate sets of 
primers were designed to amplify either Mb_vht or Ma_vht. Primer specificity was 
confirmed by PCR (Figure 3.3). The β-glucuronidase gene from E. coli (uidA), 
which is commonly used in Methanosarcina reporter gene assays (10, 26), was 
placed under regulation of Ptet and moved into M. acetivorans, M. barkeri, and M. 
barkeri Δhyd as a control for promoter strength. Under inducing conditions, the 
uidA mRNA abundance (fold difference vs. rpoA1) does not significantly vary 
between the strains, thereby indicating transcription from Ptet is approximately 
equivalent in M. acetivorans and M. barkeri (Figure 3.4A). However, under non-
inducing conditions uidA mRNA abundance is slightly elevated in M. barkeri 
strains when compared to M. acetivorans. This may indicate that repression of 
Ptet transcription initiation by TetR is not as stringent in M. barkeri (10). 
Measurements of vht mRNA abundance from PtetMb_vht and PtetMa_vht in 
M. barkeri Δhyd and M. acetivorans strongly suggest that M. acetivorans has 
promoter-independent transcriptional regulatory mechanisms that are absent in 
M. barkeri. Accordingly, induced levels of PtetMb_vht mRNA were approximately 
6-fold more abundant in M. barkeri Δhyd when compared to M. acetivorans 
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(Figure 3.4B). Interpretation of the data for PtetMa_vht is complicated by the 
presence of the endogenous vht operon in addition to the recombinant allele in M. 
acetivorans. Given the strong repression of PtetuidA and PtetMb_vht under non-
inducing conditions in M. acetivorans, we assume that Ma_vht transcripts 
detected in the absence of tetracycline can be attributed to the endogenous vht 
locus. If so, the exogenous Ma_vht transcript levels from induced PtetMa_vht are 
76-fold lower in M. acetivorans than in M. barkeri Δhyd. These results are 
consistent with those observed in the unmodified host strain (Figure 3.4C), in 
which Ma_vht transcript abundance is similar to that of the uninduced PtetMa_vht 
strain (Figure 3.4B).  
 
 
Figure 3.3. Specificity of primers utilized for qRT-PCR. A single set of primers 
amplifies a 103 base pair (BP) portion of the RNA polymerase gene, rpoA1, from 
wild type M. acetivorans (Ma), wild type M. barkeri (Mb), and the M. barkeri strain 
lacking all hydrogenases (MbΔ). Primers designed to detect vht from M. barkeri 
(Mb_vht) only amplify the 112 BP amplicon in Mb. Likewise, primers designed to 
detect vht from M. acetivorans (Ma_vht) only amplify a 100 BP region in Ma. 
 
Further, Ma_vht mRNA in wild type M. acetivorans was ca. 11-fold less 
abundant than Mb_vht mRNA in wild type M. barkeri. Additionally, when 
transcribed from the native promoter, Mb_vht mRNA was ca. 20-fold less 
abundant in M. acetivorans than in M. barkeri Δhyd (Figure 3.4C). However,  
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Figure 3.4. Hydrogenase 
regulation at the transcriptional 
level. Abundance of mRNA was 
detected via qRT-PCR, and 
compared against rpoA1, an RNA 
polymerase gene. A) To determine 
if expression from the tetracycline-
inducible promoter (Ptet) was 
consistent across Methanosarcina 
strains, transcript levels of the 
uidA reporter gene under control 
of Ptet were measured in M. 
acetivorans (M. acet.), M. barkeri 
(M. bar.), and the M. barkeri strain 
lacking all hydrogenases (M. bar. 
Δhyd). Similar levels of uidA 
transcript were measured under 
inducing conditions (+ tetracycline) 
for all three strains. B) Induced 
expression of the M. bar. and M. 
acet. versions of the vht operon 
(PtetMb_vht and PtetMa_vht) 
produced transcript in both M. bar. 
Δhyd and M. acet, but to a lesser 
extent in M. acet. C) The vht 
operon was expressed from the 
native promoter in wild type (WT) 
strains, although vht transcript was 
less abundant in M. acet. 
Expression of the M. bar. vht 
operon with the native promoter 
(Mb_vht) was equivalent to 
expression of the M. acet. vht 
operon (Ma_vht) in M. acet. 
However, both transcript levels 
were lower than that of Mb_vht when expressed in M. bar. Δhyd. Diminished vht 
transcript abundance in M. acetivorans from inducible (B) and native (C) 
promoters suggests regulation of vht in a promoter-independent manner. Error 
bars represent standard deviation for triplicate measurements of three biological 
replicates. 
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Ma_vht and Mb_vht mRNA were equally abundant in M. acetivorans. This is 
perhaps unsurprising, as the promoter regions for Ma_vht and Mb_vht are ca. 
75% identical, with a conserved putative B recognition element (BRE), TATA box, 
and transcriptional start site (Figure 3.5) (11). Thus, diminished amounts of 
mRNA from native and induced expression of Ma_vht and Mb_vht in M. 
acetivorans as compared to M. barkeri suggests a regulatory mechanism that 
operates independent of the promoter. It follows logically that a conserved 
segment of the coding sequence may serve as a signal for early transcription 
termination or mRNA degradation. 
 
 
 
Figure 3.5. The vht operon promoter region from M. acetivorans and M. 
barkeri. The promoter regions from M. acetivorans (Ma_vht) and M. barkeri 
(Mb_vht) are highly similar, and have conserved sequences for putative B 
recognition element (BRE), TATA box, transcription start site, ribosome binding 
site, and start codon (highlighted in red in the order listed). 
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Translation of Vht in Methanosarcina strains 
The presence of vht mRNA from all promoter and operon combinations in 
M. acetivorans (Figure 3.4) indicated that this organism was potentially capable 
of producing Vht protein, despite the inability to produce an active hydrogenase 
(Figure 3.2). To determine if Vht is translated, a TAP-tag was introduced at the 
Ma_vhtA, Ma_vhtC, Mb_vhtA, or Mb_vhtC native loci in M. acetivorans or M. 
barkeri. Strains containing tagged versions of the Ma_vht or Mb_vht operons 
under control of Ptet were also generated, and production of Vht was detected via 
immunoblotting. Ma_VhtC or Ma_VhtA were not detected in M. acetivorans when 
expression was driven by the native promoter (Figure 3.6). However, bands 
corresponding to Ma_VhtC (31 kDa) and Ma_VhtA (65 kDa) could be detected in 
M. acetivorans and M. barkeri Δhyd when overexpressed from induced Ptet. An 
additional ca. 80 kDa band was detected when Ma_VhtA was overexpressed, 
potentially due to protein aggregation. The lack of Ma_Vht when expressed from 
the native promoter suggests M. acetivorans contains a mechanism for 
translation inhibition. Overexpression upon induction of Ptet may allow for this 
regulatory mechanism to be overcome. 
Potential post-translational regulatory mechanisms were observed from 
Mb_Vht immunoblots. Mb_VhtC (29 kDa) and Mb_VhtA (64 kDa) were detected 
when expressed from the native locus in M. barkeri, and when overexpressed 
from induced Ptet in both M. barkeri Δhyd and M. acetivorans (Figure 3.6). A band 
of ca. 20 kDa, potentially corresponding to a degradation product, was also 
detected for Mb_VhtC when expressed in M. barkeri, but not in M. acetivorans.  
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Figure 3.6. Vht production from native (PWT) or tetracycline-inducible (Ptet) 
promoters. Production of the M. acetivorans or M. barkeri versions of Vht 
(Ma_Vht or Mb_Vht) was detected by immunoblotting with antibodies specific to 
an affinity tag introduced at the C-terminus of VhtC or N-terminus of VhtA. 
Production of Ma_VhtC (31 kDa) or Ma_VhtA (65 kDa) was not detected when 
expressed from PWT in M. acetivorans (Ma). However, both subunits were 
detected when overexpressed from Ptet in Ma or the M. barkeri strain lacking all 
hydrogenases (MbΔ). Conversely, production of Mb_VhtC (29 kDa) and 
Mb_VhtA (64 kDa) could be detected when expressed from PWT in M. barkeri 
(Mb) and when overexpressed from Ptet. Several bands corresponding to proteins 
smaller than the expected size, including a prominent ca. 20 kDa band for 
Mb_VhtC, were likely due to protein degradation. In all instances of VhtA 
overexpression, a band corresponding to a protein of ca. 80 kDa was detected, 
which potentially due to protein aggregation. When Mb_VhtA was overexpressed 
from Ptet, an additional band that was slightly larger than the expected size was 
detected. While MbΔ produces a protein of both the expected size and the 
slightly larger size, Ma produces only the slightly larger protein band. 
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Additional bands were also detected for Mb_VhtA when overexpressed in both M. 
barkeri Δhyd and M. acetivorans. Three distinct bands are detected in M. barkeri 
Δhyd; a band of the expected size that aligns with the band from native Mb_Vht 
expression, a band corresponding to a slightly larger protein, and a band of ca. 
80 kDa. In M. acetivorans, only the latter two bands are found. As the subunit 
containing the [NiFe] active site, VhtA requires proteolytic cleavage of a C-
terminal tail in order to produce a fully active enzyme (24). The lack of a band 
corresponding to the expected size, and the presence of the slightly larger band 
indicate M. acetivorans may be incapable of converting Vht into a mature 
enzyme. 
 
Discussion 
With this study we conclusively show that despite an inability to 
metabolize H2, M. acetivorans encodes an active hydrogenase, which challenges 
the notion that hydrogenases are pseudogenes in this species of Methanosarcina 
(11). However, it is apparent that M. acetivorans has mechanisms to disable Vht 
hydrogenase activity at multiple regulatory levels. At the transcriptional level, 
Ma_vht mRNA production from the native promoter was 11-fold less abundant 
than native transcription of Mb_vht in M. barkeri (Figure 3.4). Nevertheless, it 
might be expected that the smaller amount of Ma_vht mRNA could still be 
translated into protein, yet this was not the case, as protein from the natively 
expressed Ma_vht operon was not detected (Figure 3.6). Additionally, 
overexpression of vht from an inducible promoter yielded inactive protein, 
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thereby illuminating a level of post-translational control (Figure 3.2). Detecting 
regulation of hydrogenases at these levels helps to expand our meager 
understanding of archaeal gene regulation. 
Contrary to previous evidence that suggests hydrogenase inactivation is 
due to promoter inhibition (11), data from this study indicates the coding 
sequence (CDS) plays an important role in regulation. Regardless of promoter 
type (native or inducible), vht mRNA abundance is diminished in M. acetivorans 
when compared to M. barkeri (Figure 3.4). The lower level of vht transcript when 
driven by Ptet under inducing conditions suggests a segment of the CDS serves 
as a mRNA processing signal that can lead to targeted decay in M. acetivorans, 
or enhanced stability in M. barkeri (27, 35). Interestingly, the signal contained in 
the CDS is likely conserved in Ma_vht and Mb_vht, as both operons had 
diminished transcript levels in M. acetivorans as compared to M. barkeri. These 
data also indicate the mechanism likely involves a trans-acting regulatory 
element, such as a small non-coding RNA (sRNA), which is exclusive to either M. 
barkeri (for stability) or M. acetivorans (for decay) (4, 5). However, the precise 
mechanism of transcriptional control remains uncertain. 
Efficient translation is dependent on the stability of mRNA; therefore, 
regulation at transcriptional and translational levels is potentially interconnected. 
A potential mechanism that affects both transcription and translation involves 
trans-acting sRNAs. In bacteria, regulation via binding of sRNAs can occur 
through many mechanisms, including targeting mRNA for degradation or 
occlusion of the ribosomal binding site (RBS), thereby inhibiting translation (8). 
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The study of sRNA-mediated regulation in archaea is still in the early stages, 
however several sRNAs have been identified in species of Methanosarcina (3, 5, 
12, 13, 25). Additionally, a few sRNAs have been shown to regulate gene 
expression by inhibiting translation via RBS masking in Methanosarcina mazei (3, 
13, 25). The known mechanisms for sRNA-mediated regulation align with what 
was detected for M. acetivorans vht expression; i.e. lower levels of vht mRNA 
and a lack of translation from the native promoter (Figures 3.4 and 3.6). However, 
due to imperfect base pairing of trans-acting sRNAs, detection of their target 
molecule is often difficult to determine. Thus, identification of the mechanism for 
translational control in M. acetivorans remains a subject for future experiments. 
Overexpression of Vht from an inducible promoter led to the production of 
inactive Vht in M. acetivorans (Figures 3.2 and 3.6), which indicates regulation at 
the transcriptional and translational levels can be overcome, and that an 
additional level of post-translational control must be present in M. acetivorans. A 
potential source of this control is in the hydrogenase maturation process, as 
facilitated by the gene products of hypCDABE, hypF, and an endopeptidase (e.g. 
vhtD). Without the coordinated activity of the maturation enzymes, hydrogenases 
cannot form the active [NiFe]-containing holoenzyme (28). In the final maturation 
step, the endopeptidase recognizes the [NiFe]-containing subunit (e.g. VhtA) only 
after nickel is inserted, and cleaves a C-terminal peptide that allows for a final 
conformational change (28). The apparent inability of M. acetivorans to remove 
this peptide (Figure 3.6) indicates the proteolysis step, or the maturation and 
nickel-inserting steps preceding it, are inactive. As neither Ma_Vht nor Mb_Vht 
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were active in M. acetivorans, but both were active in M. barkeri, the VhtD 
endopeptidase from both organisms are likely active enzymes. Thus, prior 
hydrogenase maturation steps may be inactivated in M. acetivorans. 
It should be noted that there is a single exception to M. acetivorans’ 
inability to produce an active hydrogenase. The M. barkeri Ech hydrogenase 
produces significant hydrogenase activity when expressed in M. acetivorans, and 
facilitates the production of small amounts of methane from H2-CO2 in cell 
suspensions (9). Importantly, this indicates that the proteins required for 
synthesis and insertion of the [NiFe] active site, HypF and HypCDABE, must be 
active in M. acetivorans. However, Ech is distinct from other hydrogenases 
utilized by Methanosarcina species in two ways. First, M. acetivorans does not 
encode a version of Ech, and would therefore not be expected to have trans-
acting sRNAs that potentially regulate transcription or translation of the ech 
operon. Second, the [NiFe]-containing subunit of Ech does not have the C-
terminal peptide sequence, and does not require proteolysis by an 
endopeptidase for enzyme activation (28, 32). These data indicate post-
translational inactivation of Vht is likely due to an inability to cleave the C-terminal 
peptide, and that production of active Ech in M. acetivorans is due to a bypass in 
the proposed mechanisms for inhibition of Vht. 
Finally, it would be reasonable to ask why M. acetivorans maintains an 
active hydrogenase that is very specifically repressed. It is possible that the 
hydrogenases are required for conditions that have not yet been tested in 
laboratory settings. This might include specific substrate concentrations or 
 122 
combinations, co-culture with other microorganisms, or other conditions found in 
the natural environment but not reproduced in culture. It is also possible that 
repression of hydrogenases is a relatively recent innovation in M. acetivorans, 
and that inactivating mutations have not yet accumulated in the coding sequence 
(18). Both possibilities are a rich source of future investigations, which will 
expand our understanding of Methanosarcina evolution and physiology.  
 
Materials and methods 
Media and growth conditions 
 Methanosarcina strains were grown anaerobically at 37 °C in bicarbonate-
buffered high-salt (HS) liquid medium with 125 mM methanol, and with single-cell 
morphology (19, 30). Strains were also grown on agar-solidified medium in an 
intrachamber anaerobic incubator with an atmosphere of H2/CO2/H2S 
(79.9/20/0.1) for M. barkeri strains, or N2/CO2/H2S (79.9/20/0.1) for M. 
acetivorans strains (1, 21). Puromycin (CalBioChem, San Diego, CA) was added 
at a final concentration of 2 μg/ml for selection for the puromycin transacetylase 
gene (pac), and 8-aza-2,6-diaminopurine (8-ADP; R. I. Chemical Inc., San Diego, 
CA) was added at a final concentration of 20 μg/ml for selection against the 
presence of hpt (26). Tetracycline was added at a final concentration of 100 
μg/ml to induce transcription of the tetracycline-inducible promoter, Ptet(O1) (10). 
Standard conditions were used for growth of E. coli in liquid and agar-solidified 
LB media. E. coli WM4489, a derivative of DH10B that has been engineered to 
control oriV-based-plasmid copy-number, was used for all plasmid construction 
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steps. Plasmid copy-number was increased by supplementing LB media with 10 
mM rhamnose (15). 
 
Plasmid construction 
 A description of the plasmids used in this study is listed in Table 3.1. 
Standard methods were used for plasmid DNA manipulation in E. coli, including 
plasmid DNA purification with the Zyppy Plasmid Miniprep Kit by Zymo Research 
(Irvine, CA). Double-stranded DNA fragments, as listed for each plasmid in Table 
3.1, were either synthesized by PCR amplification or obtained as “gBlocks” from 
Integrated DNA Technologies (Skokie, IL). The Phusion High-Fidelity DNA 
Polymerase (New England BioLabs, Ipswich, MA) was used in all PCR reactions, 
and primers are listed in Table 3.2. DNA fragments were moved into vector 
backbones by the Gibson assembly method (6). Linearization of vector 
backbones was performed with restriction endonucleases obtained from New 
England BioLabs. When appropriate, plasmids were retrofit with pAMG40 via the 
BP Clonase II master mix (Invitrogen, Carlsbad, CA), in order to enable 
autonomous plasmid replication within Methanosarcina strains (10). All plasmids 
were verified by restriction endonuclease analysis and Sanger sequencing via 
the Roy J. Carver Biotechnology Center at the University of Illinois at Urbana-
Champaign. 
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Tandem affinity purification (TAP)-tag design 
 Plasmids were constructed to introduce a TAP-tag at the N- or C-terminus 
of VhtA or VhtC of M. barkeri and M. acetivorans via the CRISPR-Cas9 system 
(23). The TAP-tag consists of a 3X FLAG tag linked to a Twin-Strep II tag (7). 
The 3X FLAG tag amino acid sequence is based off the system from Sigma-
Aldrich (St. Louis, MO), and contains an enterokinase cleavage site. The Twin-
Strep II tag amino acid sequence is based off the system from IBA Lifesciences 
(Göttingen, Germany). DNA sequences for N- and C-terminal versions of the 
TAP-tag can be found in Table 3.3. Design of CRISPR-Cas9 plasmids for 
modifying the genome of Methanosarcina strains has been previously described 
(23). In brief, single guide RNA (sgRNA) target sequences were identified by the 
“Find CRISPR Sites” tool in Geneious version R9 (14), and included in the 
sgRNA sequence template (Table 3.4). Plasmids have cas9, the sgRNA 
sequence, and a repair template that includes the TAP-tag along with upstream 
and downstream homology regions (Table 3.1). Cleavage of the genome at the 
target sequence by Cas9 forces the introduction of the repair template via 
homologous recombination. An introduced synonymous nucleotide substitution in 
the protospacer adjacent motif (PAM) precludes repeated cleavage by Cas9 
(Table 3.2).  
 
Methanosarcina strain construction 
 All strains used in this study are listed in Table 3.5. The liposome-
mediated transformation technique was utilized to introduce plasmid DNA into 
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Methanosarcina strains (20). Constructed strains were verified by PCR and 
Sanger sequencing via the Roy J. Carver Biotechnology Center at the University 
of Illinois at Urbana-Champaign. 
 
Hydrogenase enzyme activity assays 
 Assays were performed with cell extract harvested from 10 ml culture 
grown to mid-exponential phase in HS medium with 125 mM methanol as 
previously described (17). All cell lysis steps and enzyme assay measurements 
were performed within an anaerobic chamber under an atmosphere of H2/N2 
(4%/96%). The hydrogenase reaction was initiated at room temperature by 
introduction of 2 mM benzyl viologen, and activity was determined by measuring 
the absorbance change at 578 nm (extinction coefficient, 8.65 cm-1 mM-1). 
Absorbance was measured with a Cary 50 UV-Vis Spectrophotometer (Agilent, 
Santa Clara, CA) linked to the cell holder located within the anaerobic chamber 
via fiber optic cable (Hellma Analytics, Müllheim, Germany). One unit of 
hydrogenase activity (U) was defined as the reduction of 1 μmol benzyl viologen 
per minute. Three independent measurements from biological replicates were 
performed for each strain. Protein concentration was measured by the Bradford 
method (2). 
 
Quantification of mRNA abundance via qRT-PCR 
 Cultures were grown to mid-exponential phase in 10 ml HS medium with 
125 mM methanol, with and without the addition of 100 μg/ml tetracycline. For 
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RNA extraction, 5 ml culture was removed and combined with an equivalent 
volume of TRIzol reagent (Ambion, Carlsbad, CA). Samples were incubated at 
room temperature for 5 min. to ensure cell lysis. RNA isolation was then 
performed with the Direct-zol RNA MiniPrep kit from Zymo Research according 
to manufacturer’s directions. Samples were treated with DNase I, cleaned with 
the RNA Clean & Concentrator kit (Zymo Research), and diluted to 50 ng/ml in 
RNase-free H2O. RNA samples were stored at -80 °C. For the qRT-PCR reaction, 
the SuperScript III Platinum SYBR Green One-Step qRT-PCR Kit by Invitrogen 
was used per the manufacturer’s directions. A 25 μl reaction was used, with a 
total of 200 ng RNA per reaction. Primers for analysis of vht mRNA abundance 
were designed to amplify in a species-specific manner (i.e. primers for Mb_vht 
would only amplify Mb_vht and not Ma_vht, and vice versa). A single set of 
primers was used to detect rpoA1 in both species (Figures 3.3, 3.7, and Table 
3.2). For each sample, controls included reactions that lacked the reverse 
transcriptase and reactions that lacked RNA template. The Mastercycler ep 
realplex (Eppendorf, Hamburg, Germany) was used for qRT-PCR measurements 
and analysis. RNA was extracted from all strains in triplicate from independent 
biological replicates, and each replicate was in turn analyzed by triplicate qRT-
PCR measurements (9 total measurements per strain and growth condition). 
Significant differences in mRNA abundance between strains was determined by 
the two-sample Welch’s t statistic with assistance from the Illinois Statistics Office 
at the University of Illinois at Urbana-Champaign. 
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Detection of Vht protein production via immunoblotting 
 Cultures were grown to mid-exponential phase in 10 ml HS medium with 
125 mM methanol, and with or without the addition of 100 μg/ml tetracycline. 
Cells were collected by centrifugation at 16,000 x g at room temperature in an 
Eppendorf 5418 microcentrifuge. Cells pellets were kept on ice and broken in 
200 μl Lysis Buffer [50 mM MOPS (3-(N-Morpholino) Propane-Sulfonic Acid) at 
pH 7.0, 2% Triton X-100, bovine pancreas deoxyribonuclease I, c0mplete EDTA-
free protease inhibitor cocktail (Roche)]. Protein-containing supernatant was 
separated from cell debris by centrifugation at 16,000 x g for 5 min (Eppendorf 
5418 centrifuge), and protein concentration was measured by the BCA method 
(Pierce Biotechnology, Rockford, IL) (29). Samples were diluted to 2 mg/ml in 
Lysis Buffer, and combined with an equivalent volume of 2X Laemmli buffer (Bio-
Rad, Hercules, CA) containing 5% 2-mercaptoethanol. Samples for analysis of 
VhtA production were boiled for 10 min., and samples for VhtC analysis were 
incubated at room temperature for 20 min. Boiling of VhtC samples caused most 
protein to form a large aggregate. Protein was separated via SDS-PAGE with a 
10% Mini-PROTEAN TGX Precast gel (Bio-Rad) loaded with 5 μg protein per 
well, and then transferred to an Immobilon-P Transfer Membrane (Millipore, 
Burlington, MA) per the manufacturer’s instructions. To detect the TAP-tagged 
subunits, membranes were first blotted with the primary antibody, monoclonal 
Anti-FLAG M2 produced in mouse (Sigma-Aldrich); and then blotted with the 
secondary antibody, goat anti-mouse IgG (H+L) conjugated to stabilized 
peroxidase (ThermoFisher Scientific, Waltham, MA). For visualization, 
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membranes were incubated with Pierce ECL Western Blotting Substrate (Pierce 
Biotechnology) per the manufacturer’s instructions, and then exposed to HyBlot 
CL autoradiography film (Denville Scientific Inc., Metuchen, NJ).  
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Table 3.3. Tandem affinity purification (TAP)-tag DNA sequences1 
N-terminal 
ATGGACTACAAGGACCACGACGGTGACTACAAGGACCACGACATCGACTACAAAGACGATGACGACAAGGGTTCCGCTGCATCCTGGTCACATCCTCAGTTTGAAAAAGGTGGCGGGTCAGGCGGGGGTTCAGGGGGTGGCTCATGGTCACATCCTCAGTTTGAAAAATCAGGT 
C-terminal 
GGTTCCGCTTGGTCACATCCTCAGTTTGAAAAAGGTGGCGGGTCAGGCGGGGGTTCAGGGGGTGGCTCATGGTCACATCCTCAGTTTGAAAAAGGCGCTTCCGGTGAAGACTACAAGGACCACGACGGTGACTACAAGGACCACGACATCGACTACAAAGACGATGACGACAAG 
1 Single-underlined region indicates location of FLAG-tag. Double-underlined 
region indicates location of Strep II-tag. 
  136 
Table 3.4. Sequences of elements required for CRISPR-Cas9-mediated DNA 
modifications. 
Gene sgRNA target sequences (+PAM) 
M. acetivorans vhtA TTACAGTCGATCCTTTAACC AGG 
M. acetivorans vhtC AAAGGCTCCTGAAGCCATAA AGG 
M. barkeri vhtA GTGGCCTTCAATTCTGGTTA AGG 
M. barkeri vhtC AGTATCTTCCTACAGAGGAA AGG 
sgRNA sequence template1, 2 TTTTTCGAAGTTTAAACCTGCAGGCGCGCCAACAACATCAGTCACCTAAAAAGAGAAAACGAATTACACGATCACTAATTTTAAATTTTATATATGTTGACTGAGATTGCAAATTTGAACATTGAAATTTTTTACCCGCTTGATCTGAATAATGACATTGTTCAAAAAAAGTACAAATGATAAAAAAGAAAGCTTCTCAAAAAACAGTAAAGAAGTTCTCCCCAAAATCACCTCAAAAATTCAGAGCTCTATTATCAGAAAAAGCGAGCTTAAAAAATTCAAAGGAAAGATACCCCTCTGCACCCTCAAAATTTTAGACCCTGTGTTGACCTGTAAAAATCAGGAAAAAATTTCCGTCGGTTATGGTATATGTGATGATTTCCCCTAATTATGCTGTAAGCACATGTN
NNNNNNNNNNNNNNNNNNNGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTTGCCCTCAGTTCTCTTTTTCTTTTTCTTAAACTTCACGCACTGCACTTTTGTCCTCACTTTTTTCATGCCGTCAGATTAACTACTTTTTCTATCCTTGAAATCAGCGGCTTTTCAGCCCTCATGTAGGCGCGCCGGCGATCGCGGCCGCTTAATTA 
1 Underlined region indicates 5’ extension overhang for Gibson assembly. 
2 Emboldened region indicated where the sgRNA target sequence (without the 
PAM) is inserted into the template. 
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Figure 3.7. Primer binding regions for qRT-PCR. The location of the region 
amplified for qRT-PCR detection is shown as a blue line for the M. barkeri 
version of vht (112 bp), a green line for the M. acetivorans version of vht (100 bp), 
or a black line for rpoA1 from both strains (103 bp). The genomic region of the 
amplified sequence is enlarged and surrounded by a dashed line. Primer binding 
locations are underlined; amplified regions are emboldened and italicized. 
Primers for detection of vht are strain-specific, and primers for rpoA1 amplify the 
gene from both strains. 
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Chapter 4: Summary and future directions 
 
A versatile metabolism endows Methanosarcina species with an ability to 
use a relatively wide range of substrates for methanogenesis via four overlapping 
pathways (7, 17, 18, 29). Recently, it has been shown that Methanosarcina 
barkeri can utilize H2 as a substrate in some methanogenic pathways and as an 
electron carrier via a hydrogen cycling mechanism in other pathways. However, 
M. barkeri also contains a H2-independent electron transport system that does 
not require the use of hydrogenase enzymes (14, 15). In Chapter 2, we 
expanded our understanding of the interconnected nature of M. barkeri metabolic 
pathways by measuring the effects of hydrogenase gene deletions on growth, 
methanogenesis, and gene regulation. Another species, Methanosarcina 
acetivorans, is incapable of metabolizing H2, yet encodes hydrogenases that are 
highly similar to the enzymes found in M. barkeri. In Chapter 3, I found that the M. 
acetivorans encoded Vht hydrogenase is a functional enzyme when expressed in 
M. barkeri, but is inactivated in the native host by regulation at the transcriptional, 
translational, and post-translational levels. As with any scientific inquiry, answers 
stemming from experimental results are commonly accompanied by new 
questions. In the final section of this chapter, I will outline a few potential projects 
for continued investigation of energy metabolism in Methanosarcina. 
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Significant findings 
Metabolic flexibility of M. barkeri 
The interconnected nature of M. barkeri energy conservation pathways 
was explored in Chapter 2, where we discovered an unexpected example of 
metabolic flexibility in a mutant strain lacking the F420-reducing hydrogenase 
(Frh). It is known that this enzyme is required for growth with H2-CO2, and is most 
likely used to provide reduced F420 (F420red) for two reduction steps in the 
conversion of CO2 to methane (14, 28). As expected, strains lacking Frh were 
unable to grow with H2-CO2 as the sole substrates; however, this strain was still 
able to produce a small amount of methane from H2-CO2 in cell suspensions. We 
speculate that production of F420red required for methanogenesis could occur 
through two different pathways in Frh-deficient strains. The first is facilitated by 
the Vht hydrogenase and a reversal of the F420 dehydrogenase (Fpo), wherein 
H2 oxidation by Vht generates reduced methanophenazine, which is used by Fpo 
to produce F420red. The second pathway could occur through an electron 
bifurcation mechanism via a soluble heterodisulfide reductase enzyme (HdrABC) 
(1, 31). With this mechanism, reduced ferredoxin (Fdred) generated by the Ech 
hydrogenase is used to reduce both F420 and the disulfide of coenzyme M and 
coenzyme B (CoM-CoB) that is produced in the terminal methane-generating 
step. In each case, an alternate hydrogenase is required, and combining the frh 
deletion with a deletion of each of the other hydrogenases (i.e. Δfrh Δvht or Δfrh 
Δech) eliminates methane production in cell suspensions. Thus, either 
mechanism is potentially functional in M. barkeri.  
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 Another example of M. barkeri’s metabolic flexibility was found in a strain 
that lacked all hydrogenases, yet was capable of growth with methylotrophic 
substrates (i.e. methanol). This strain converted methanol to methane and CO2 in 
the same 3:1 ratio found in wild type M. barkeri, suggesting efficient electron 
transfer between oxidative and reductive portions of the methylotrophic pathway. 
Ordinarily, reducing equivalents from the oxidative portion (in the form of F420red 
and Fdred) are transferred to the reductive portion by the hydrogen cycling 
mechanism that involves all three hydrogenases (14, 15, 20, 21). The Frh and 
Ech hydrogenases produce H2 from F420red and Fdred, which is consumed by Vht 
to produce the reduced methanophenazine required to reduce CoM-CoB by the 
membrane-bound heterodisulfide reductase (HdrED). Without hydrogenases, an 
alternate route for electron transfer must be utilized. The Fpo and HdrED 
enzymes are a known pathway for F420red:CoM-CoB electron transfer, however 
a Fdred:CoM-CoB electron transfer mechanism has not been established in M. 
barkeri (4, 14). A potential candidate to facilitate this process is the HdrABC 
enzyme mentioned above. With this mechanism, CoM-CoB would be directly 
reduced with electrons from Fdred, along with concomitant production of F420red 
(1, 31). Further characterization of HdrABC will provide a clearer understanding 
of the electron transport network in M. barkeri.  
 
H2-mediated inhibition of the oxidative branch of methanogenesis  
 In Chapter 2 we also determined that active hydrogenases were required 
for H2-mediated inhibition of the oxidative branch of the methylotrophic 
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methanogenic pathway in M. barkeri. During methanogenesis from methanol 
alone, a portion of the substrate is oxidized to CO2, which provides reducing 
equivalents for reduction of other methanol molecules to methane, leading to 
production of methane and CO2 at a 3:1 ratio. When H2 is included as a substrate, 
methanol is entirely reduced to methane with no CO2 production, indicating the 
methanol oxidation pathway is not utilized (21). However, a M. barkeri strain 
lacking all hydrogenases was able to grow with methanol plus H2, and produced 
methane and CO2 in a 3:1 ratio from these substrates. Therefore, the presence 
of H2 alone is insufficient for suppression of the oxidative branch. Additional 
evidence from other hydrogenase mutants indicated that all three hydrogenases 
are involved in suppression. Accordingly, strains containing a single active 
hydrogenase produced low levels of CO2, and a complete removal of 
hydrogenases was required for methanol oxidation to CO2 to no longer be 
suppressed. The hydrogenase requirement for inhibition of oxidation indicates 
that their enzymatic products (i.e. reduced electron carriers F420, Fd, and 
methanophenazine) potentially mediate suppression by limiting the availability of 
oxidized electron carriers.  
 
Redox-sensing based gene regulation 
 Transcriptional profiling of hydrogenase mutants in Chapter 2 indicated 
that M. barkeri is able to regulate genes based on the redox state of electron-
carrying cofactors. In every strain that lacked frh, the fpo operon was up-
regulated, which is the only alternate route for reducing equivalents in the form of 
 149 
F420red to be transferred between oxidation and reduction portions of the 
methylotrophic pathway (14). Thus, the lack of Frh may lead to redox imbalance 
of F420 during methylotrophic growth, which is resolved by increasing expression 
of Fpo in M. barkeri. Furthermore, this response indicates that M. barkeri has a 
mechanism to sense the redox state of F420 and affect gene transcription. A 
global regulator, MreA, has been identified in Methanosarcina, and has been 
shown to repress fpo transcription. However, the sensory input and mechanism 
of regulation are unknown (26). Identifying the mechanism for gene regulation 
based on sensing the redox state of electron carriers is a source for future 
experimentation. 
  
The balance of hydrogenase activity during hydrogen cycling 
 The recently published hydrogen cycling model for energy conservation in 
M. barkeri showed that efficient capture of H2 by Vht is required for continued 
methanogenesis and to prevent cell death, presumably from redox imbalance 
(15). A strain expressing Frh, the internal H2-producing hydrogenase, but not Vht, 
the external H2-consuming hydrogenase, rapidly accumulates H2 in the culture 
headspace, ceases methanogenesis, and lyses. Thus, it would seem that the 
activities of Frh and Vht must be balanced to prevent excessive loss of reducing 
equivalents to the environment. By measuring hydrogenase activity of each 
hydrogenase mutant in Chapter 2, I determined that Frh activity is actually 3-fold 
higher than Vht. However, upon extrapolating in vivo activities of each 
hydrogenase based on our values measured with an artificial electron acceptor 
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and values measured with native redox cofactors found in the literature, we found 
Frh activity to be closer to 1.5-fold higher than Vht activity. Therefore, the 
relatively close values for Frh and Vht hydrogenase activity further support the 
hydrogen cycling mechanism for energy conservation. 
 
M. acetivorans encodes an active hydrogenase 
 M. acetivorans is incapable of metabolizing H2 and lacks detectable 
hydrogenase activity, yet encodes the Frh and Vht hydrogenases with a high 
level of amino acid sequence identity to the active homologs found in M. barkeri 
(7, 9). However, despite the apparent inability to use hydrogenases, I showed in 
Chapter 3 that substantial hydrogenase activity is detected from the M. 
acetivorans version of Vht when expressed in M. barkeri. In fact, the M. barkeri 
and M. acetivorans versions of Vht have approximately equivalent activities when 
expressed in M. barkeri. Thus, M. acetivorans must either contain a mechanism 
for specifically inactivating Vht hydrogenase activity, and/or lack the machinery 
required to form a fully active Vht. Maintaining a functional hydrogenase 
potentially suggests that M. acetivorans has the ability to metabolize H2 under 
conditions that have not yet been tested in laboratory settings. Additional 
information about the regulation of hydrogenases in M. acetivorans might be 
gained by attempting similar heterologous expression experiments with the M. 
acetivorans version of Frh. However, expression of Frh alone in M. barkeri is fatal, 
so experiments testing for activity of M. acetivorans’ version of Frh must be 
carefully designed (15). 
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Promoter-independent regulation of vht expression in M. acetivorans 
 The presence of a functional, yet apparently unutilized hydrogenase in the 
genome of M. acetivorans led me to investigate the regulatory mechanisms that 
control its expression. Previous studies indicated that inhibition of hydrogenase 
expression occurred via promoter inactivation (9). However, in Chapter 3 I 
showed that the vht coding sequence also has an important role in regulation. 
When expressed from either native or inducible promoters, vht mRNA was 
significantly less abundant in M. acetivorans as compared to expression in M. 
barkeri. Additionally, the M. acetivorans and the M. barkeri versions of vht both 
had diminished mRNA levels when expressed in M. acetivorans. Together these 
data indicate that regulation might occur via a trans-acting element that targets a 
conserved region of the vht coding sequence. Candidates for this regulatory 
element include small non-coding RNAs (sRNAs), which have been shown to 
regulate gene expression in some Methanosarcina species (2, 5, 10, 11, 25). The 
model of sRNA-mediated regulation also fits data obtained for regulation of Vht 
translation in M. acetivorans, which indicated that Vht is not produced when 
expressed from the native promoter. In addition to affecting mRNA stability, some 
sRNAs have been shown to inhibit translation by binding to the ribosome binding 
site in Methanosarcina mazei (2, 11). Thus, future experiments to elucidate the 
trans-acting mechanism of vht regulation should begin with a focus on identifying 
sRNAs and their targets in both M. acetivorans and M. barkeri. 
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Post-translational control of Vht activity in M. acetivorans 
 While Vht is not translated from the native promoter in M. acetivorans, the 
protein is produced when overexpressed from an inducible promoter. This 
suggests the trans-acting transcriptional and translational controls can be 
overcome with overexpression; however, the produced protein was not an active 
hydrogenase. It is therefore apparent that M. acetivorans also regulates 
hydrogenase activity via post-translational control. In Chapter 3, I gathered data 
that suggests Vht is inactive due to an inability to properly form the [NiFe] active 
site that is required for activity. Hydrogenases utilized by species of 
Methanosarcina require specific maturation steps for the synthesis and insertion 
of the bimetallic active site, which is facilitated by the gene products of hypF and 
hypCDABE (24, 27). After proper insertion of the [NiFe] center, the final 
maturation step involves proteolytic cleavage of a C-terminal peptide by an 
endopeptidase. The slightly larger protein size detected for VhtA produced in M. 
acetivorans as compared to M. barkeri potentially indicates that the C-terminal 
peptide is not removed, and that M. acetivorans is unable to properly form the 
[NiFe] active site. However, this explanation is somewhat speculative and 
requires more extensive exploration of the protein produced in M. acetivorans. 
 
Areas for continued research 
The alternative Fdred:CoM-CoB pathway in M. barkeri 
 Electron transport from Fdred to CoM-CoB typically occurs via Ech-Vht 
hydrogen cycling and the membrane-bound heterodisulfide reductase, HdrED, in 
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M. barkeri (Figure 2.3). However, at least three lines of evidence from Chapter 2 
indicate this organism has an alternative Fdred:CoM-CoB electron transport 
pathway: i) a strain lacking all hydrogenases was able to grow via the 
methylotrophic pathway and produced methane and CO2 in a 3:1 ratio, ii) a strain 
containing only Ech, the Fd-reducing hydrogenase, was able to reduce methanol 
to methane with electrons derived from H2, and iii) a strain lacking the Frh 
hydrogenase was able to generate methane from H2/CO2 in a cell suspension 
assay, but a strain lacking both Frh and Ech was not. A likely candidate for 
alternative Fdred:CoM-CoB activity is the soluble heterodisulfide reductase 
HdrABC, as has been proposed for the homologous enzyme from M. acetivorans 
(1, 31). To investigate the function of HdrABC in M. barkeri, the genes encoding 
this enzyme should be deleted in each of the three strains mentioned above, and 
the effect on growth and methanogenesis with various substrates should be 
tested. In each case, diminished levels of methane production and potentially 
diminished growth rates would be expected. However, it may not be possible to 
delete the genes for HdrABC if this enzyme is the only alternative route for 
Fdred:CoM-CoB electron transport. In this case, expression of HdrABC could be 
driven by the tetracycline-inducible promoter, and the effect of gene suppression 
on growth and methanogenesis could be measured (8, 15). Lastly, a CRISPR-
Cas9 based system for determining gene essentiality was recently developed, 
and could also be used to establish whether HdrABC-mediated Fdred:CoM-CoB 
activity is required in the M. barkeri strain lacking all hydrogenases (22). 
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Regulation of the F420 dehydrogenase (fpo) 
 In Chapter 2, I showed that M. barkeri contains a mechanism to regulate 
gene expression that is potentially based on the detection of F420 redox 
imbalance. All strains lacking Frh, the F420-reducing hydrogenase, had 
increased mRNA abundance of the fpo operon during methylotrophic growth. To 
further explore this mechanism, I performed preliminary experiments to detect 
the region of the fpo promoter that is targeted for regulation. The experiment, in 
outline, was to drive expression of the reporter gene, uidA, by successively 
shorter promoter regions of fpo in wild type M. barkeri and a strain in which the 
frh operon was deleted (8, 15). Based on RNAseq data from Chapter 2, higher 
levels of UidA enzyme activity would be expected in Δfrh strains when the fpo 
promoter region that is targeted by a regulatory element is present. Removal of 
the targeted region in shorter promoter fragments would eliminate the differences 
in UidA activity between wild type and Δfrh strains, and thus allow identification of 
the region required for regulation. As a starting point, a promoter length of 814 
base pairs (bp) upstream of the Fpo translational start codon was selected, and 
thought to contain the entire 5’ untranslated region plus potential targeted regions 
based on analysis of RNAseq data. When driven by the 814 bp promoter, UidA 
had 1.4-fold higher activity (p-value < 0.001) in the Δfrh strain. While this follows 
with the expected results, the magnitude of the difference between wild type and 
Δfrh strains was smaller than what was detected with RNAseq (ca. 3 to 5-fold 
difference). We hypothesized that a portion of the coding region may also be 
required for regulation, as was detected in Chapter 3 for vht regulation in M. 
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acetivorans. Therefore, to account for the diminished regulatory signal detected 
from UidA activities (1.4-fold vs. 3 to 5-fold for RNAseq), the 814 bp promoter 
region along with the entire first gene of the operon (fpoA) was used to drive 
UidA expression. With this construct, UidA activity was 1.9-fold higher (p-value = 
0.0003) in the Δfrh strain, as compared to the wild type strain. Thus, the region 
targeted for fpo regulation may include a portion of the coding sequence. Future 
experiments to determine the region required for fpo regulation should continue 
with testing promoter fragments of varying sizes for differences in UidA activity in 
wild type and Δfrh strains. Establishing the targeted region will help to identify the 
mechanism of fpo regulation (e.g. regulatory protein, sRNA, etc.). 
 Alternatively, the global regulator MreA, which has been shown to affect 
fpo regulation in M. acetivorans, should be explored in M. barkeri (26). Deletion 
of mreA in M. acetivorans caused fpo to be up-regulated during growth with 
acetate, and MreA was shown to bind the fpo promoter region via electrophoretic 
mobility shift assay (EMSA). M. barkeri contains two homologs of mreA, with 
98% and 89% amino acid sequence identity to the M. acetivorans version. 
Therefore, it would be prudent to perform similar EMSA experiments with both 
versions of MreA and the fpo promoter in M. barkeri. However, the sensory input 
of MreA-mediated regulation is unknown, and therefore additional experiments 
will be required to determine whether there is a link between MreA and fpo up-
regulation in M. barkeri strains lacking Frh. This includes a comparison of fpo 
mRNA abundance in a ΔmreA single mutant versus a ΔmreA Δfrh double mutant. 
If MreA is a component of the regulatory mechanism, similar levels of fpo mRNA 
 156 
should be seen in both strains. Lastly, several other regulatory proteins were 
identified in the M. acetivorans ΔmreA mutant strain (26). Homologs of these 
proteins in M. barkeri should be analyzed in the manner described above. 
 
Coenzyme F420 requirement during growth via the methyl reduction pathway 
 The model for the methyl reduction pathway of methanogenesis, in which 
methyl compounds are reduced to methane with electrons derived from H2, 
predicts that coenzyme F420 should not be required. In Chapter 2, we showed 
that growth and methanogenesis of an M. barkeri strain lacking the F420-
reducing hydrogenase, Frh, was unaffected when methanol and H2 were used as 
substrates. Additionally, strains of Methanomassiliicoccales, which are only able 
to undergo methanogenesis via the methyl reduction pathway, do not encode 
F420-dependent enzymes and do not have detectable F420 autofluorescence 
(16, 23). To determine whether this coenzyme is required by M. barkeri during 
methyl reduction methanogenesis, I performed preliminary experiments in which I 
attempted to inactivate genes that are required for F420 biosynthesis (i.e. cofG, 
cofH1, cofH2, and cofC; Locus Tags: Mbar_A3415 to Mbar_A3417) (6). When 
these genes were placed under control of a tetracycline-inducible promoter and 
expression was repressed (8), F420 autofluorescence was substantially 
diminished. However, these strains were able to grow under non-inducing 
conditions with methanol as the sole substrate, which should require utilization of 
F420 as an electron carrier. The remaining low level of autofluorescence and 
ability to grow with methanol alone suggested that the tetracycline-inducible 
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promoter may not be fully repressed under non-inducing conditions, and that 
small amounts of F420 may still be synthesized. The results of mRNA 
abundance studies via qRT-PCR in Chapter 3 confirm this conclusion. Therefore, 
I attempted to delete the cof genes from the M. barkeri genome, but was 
ultimately unsuccessful after many attempts. An inability to cleanly delete the cof 
genes potentially suggests that F420 is an essential component of the electron 
transport network despite the model for the methyl reduction pathway predicting 
it is not required. To confirm this, future studies should utilize the CRISPR-Cas9 
system of gene deletion in order to determine the essentiality of the cof genes 
(22).  
Lastly, based on the model for aceticlastic methanogenesis, F420 should 
not be required when acetate is used as the growth substrate. It may therefore 
be tempting to try deleting cof genes in M. barkeri during growth with acetate. 
However, previous studies have established that the methyl-oxidative branch of 
the methanogenic pathway is required for growth, and that this pathway is 
potentially needed in order to generate reducing equivalents for anabolic 
reactions (7, 13). Additionally, supplementing acetate-containing growth medium 
with yeast extract, casamino acids, or methanogen cell extract did not allow 
growth of an M. barkeri mutant strain that is unable to utilize the methyl-oxidative 
pathway (7). Thus, as two steps of the methyl-oxidative process involve F420-
dependent enzymes, this approach may not be possible. 
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Interaction of Frh and Vht hydrogenases 
 Careful balancing of Frh and Vht hydrogenase activities is required to 
prevent loss of reducing equivalents in the form of escaping H2 during the 
hydrogen cycling mechanism of electron transport, as discussed above (15). 
Another system to prevent H2 loss potentially includes interaction of the 
cytoplasmic, H2-producing hydrogenase (Frh), and the membrane-bound, H2-
consuming hydrogenase (Vht), either directly or by way of an intermediate H2-
channeling protein. This is supported by an immunogold labeling study in M. 
barkeri, which showed that Frh localizes to the cell membrane (19). Additionally, I 
gathered preliminary data in which fluorescently labeled Frh was primarily 
detected at the cell membrane. However, colocalization of Frh and Vht at the cell 
membrane does not sufficiently address whether there is interaction between the 
proteins. One method to detect protein-protein interaction includes a “pull-down” 
experiment, wherein a protein is isolated via an affinity tag and other interacting 
proteins co-purify. In Chapter 3, twin-affinity purification (TAP)-tags were 
developed to detect the production of Vht in M. barkeri and M. acetivorans. To 
assess whether Frh and Vht interact, the TAP-tagged version of VhtA was 
purified from M. barkeri with Strep-Tactin resin, and proteins were identified via 
mass spectrometry. As anticipated, the VhtA and VhtG subunits were detected 
with relatively high coverage (85% and 30%, respectively). FrhA and FrhB could 
also be detected among several other proteins at low levels, and had much lower 
coverage than the Vht subunits (19% and 6%, respectively). While these data do 
not conclusively demonstrate Frh-Vht interaction, it is a promising lead, and 
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future experiments should optimize pull-down reaction conditions. Additionally, it 
may be necessary to stabilize fleeting protein interactions with chemical 
crosslinking. Lastly, the reciprocal experiment with TAP-tagged Frh may yield 
important insight into interaction of these two hydrogenases. 
 
Mechanism of species-specific Vht regulation 
 In Chapter 3 I showed that the M. barkeri and M. acetivorans versions of 
Vht are active in M. barkeri but not in M. acetivorans, which indicated that Vht is 
potentially regulated by a trans-acting element. Two possibilities may explain this 
phenomenon; i) an element that is required for production of an active Vht 
hydrogenase is exclusive to M. barkeri, or ii) an inhibitory element is contained 
only by M. acetivorans. An initial attempt was made to validate either of these 
possibilities by combining cell extracts from the two species. For the first scenario, 
extract from an M. barkeri strain lacking all hydrogenases was combined with 
extract from an M. acetivorans strain that expressed Vht from an inducible 
promoter. No hydrogenase activity was detected, which indicated that M. barkeri 
cell extract did not contain an element that was able to activate Vht in extract 
from M. acetivorans. For the second scenario, various ratios of cell extracts from 
wild type M. barkeri and wild type M. acetivorans were combined, but the 
presence of extract from M. acetivorans did not diminish hydrogenase activity. 
Thus, it seemed neither scenario could account for the lack of hydrogenase 
activity in M. acetivorans. However, these experiments presumed that the trans-
acting element was expressed and able to function in cell extracts. A more 
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accurate experiment would be to express each gene from M. barkeri in M. 
acetivorans and each gene from M. acetivorans in M. barkeri, and then test for 
gain or loss of hydrogenase activity. To accomplish this, each species should be 
transformed with a cosmid library of the genome for the other species, and 
screened for hydrogenase activity. In order to facilitate the activity screen, I have 
developed a rapid colorimetric assay via top agar impregnated with benzyl 
viologen. Any genome fragments that enable hydrogenase activity in M. 
acetivorans or disable activity in M. barkeri will easily be identified by cosmid 
sequencing. The search for elements from M. barkeri that produce hydrogenase 
activity in M. acetivorans has an advantage of containing a built in positive 
control, as the Ech hydrogenase from M. barkeri is known to be active in M. 
acetivorans (7). The identification of hydrogenase regulatory elements will 
contribute to the sparsely populated field of archaeal gene regulation. 
 
Post-translational processing of Vht in M. acetivorans 
 The Vht hydrogenase requires specific processing steps in order to be 
converted into a fully active enzyme, which includes proteolytic cleavage of a C-
terminal peptide upon proper insertion of the [NiFe] active site (24, 27, 30). In 
Chapter 3, I provided evidence that M. acetivorans is incapable of maturing the 
Vht apoenzyme into the active holoenzymatic form. When produced in M. 
acetivorans, Vht was inactive, and the active-site-containing subunit, VhtA, 
appeared to be slightly larger than the expected size, which indicated that the C-
terminal peptide may not have been excised. To confirm this finding, the VhtA 
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subunit containing an N-terminal TAP-tag should be purified from M. acetivorans, 
and analyzed by mass spectrometry. The presence of peptide fragments with 
masses corresponding to the C-terminal peptide would substantiate the results of 
immunoblotting experiments in Chapter 3. Finally, as proteolysis is the 
concluding step in the hydrogenase maturation process, it would be informative 
to measure the concentrations of nickel and iron present in VhtA to determine if 
maturation is inhibited at an earlier stage (3, 12). 
 162 
References 
1. Buan NR, Metcalf WW. 2010. Methanogenesis by Methanosarcina 
acetivorans involves two structurally and functionally distinct classes of 
heterodisulfide reductase. Mol Microbiol 75:843-853. 
2. Buddeweg A, Sharma K, Urlaub H, Schmitz RA. 2018. sRNA41 affects 
ribosome binding sites within polycistronic mRNAs in Methanosarcina 
mazei Gö1. Mol Microbiol 107:595-609. 
3. Deppenmeier U, Blaut M, Schmidt B, Gottschalk G. 1992. Purification and 
properties of a F420-nonreactive, membrane-bound hydrogenase from 
Methanosarcina strain Gö1. Arch Microbiol 157:505-511. 
4. Deppenmeier U, Müller V. 2007. Life close to the thermodynamic limit: 
How methanogenic Archaea conserve energy, p 123-152. In Schäfer G, 
Penefsky HS (ed), Bioenergetics Results and Problems in Cell 
Differentiation, vol 45. Springer, Berlin, Heidelberg. 
5. Gelsinger DR, DiRuggiero J. 2018. The non-coding regulatory RNA 
revolution in Archaea. Genes 9:141. 
6. Graham DE, White RH. 2002. Elucidation of methanogenic coenzyme 
biosyntheses: from spectroscopy to genomics. Nat Prod Rep 19:133-147. 
7. Guss AM, Mukhopadhyay B, Zhang JK, Metcalf WW. 2005. Genetic 
analysis of mch mutants in two Methanosarcina species demonstrates 
multiple roles for the methanopterin-dependent C-1 oxidation/reduction 
pathway and differences in H2 metabolism between closely related 
species. Mol Microbiol 55:1671-1680. 
8. Guss AM, Rother M, Zhang JK, Kulkarni G, Metcalf WW. 2008. New 
methods for tightly regulated gene expression and highly efficient 
chromosomal integration of cloned genes for Methanosarcina species. 
Archaea 2:193-203. 
9. Guss AM, Kulkarni G, Metcalf WW. 2009. Differences in hydrogenase 
gene expression between Methanosarcina acetivorans and 
Methanosarcina barkeri. J Bacteriol 191:2826-2833. 
10. Jäger D, Sharma CM, Thomsen J, Ehlers C, Vogel J, Schmitz RA. 2009. 
Deep sequencing analysis of the Methanosarcina mazei Gö1 
transcriptome in response to nitrogen availability. Proc Natl Acad Sci U S 
A 106:21878-21882. 
11. Jäger D, Pernitzsch SR, Richter AS, Backofen R, Sharma CM, Schmitz 
RA. 2012. An archaeal sRNA targeting cis- and trans-encoded mRNAs via 
two distinct domains. Nucleic Acids Res 40:10964-10979. 
 163 
12. Kemner JM, Zeikus JG. 1994. Purification and characterization of 
membrane-bound hydrogenase from Methanosarcina barkeri MS. Arch 
Microbiol 161:47-54. 
13. Krzycki JA, Wolkin RH, Zeikus JG. 1982. Comparison of unitrophic and 
mixotrophic substrate metabolism by acetate-adapted strain of 
Methanosarcina barkeri. J Bacteriol 149:247-254. 
14. Kulkarni G, Kridelbaugh DM, Guss AM, Metcalf WW. 2009. Hydrogen is a 
preferred intermediate in the energy-conserving electron transport chain of 
Methanosarcina barkeri. Proc Natl Acad Sci U S A 106:15915-15920. 
15. Kulkarni G, Mand TD, Metcalf WW. 2018. Energy conservation via 
hydrogen cycling in the methanogenic archaeon Methanosarcina barkeri. 
mBio 9:e01256-18. 
16. Lang K, Schuldes J, Klingl A, Poehlein A, Daniel R, Brunea A. 2015. New 
mode of energy metabolism in the seventh order of methanogens as 
revealed by comparative genome analysis of "Candidatus methanoplasma 
termitum". Appl Environ Microbiol 81:1338-52. 
17. Liu Y, Whitman WB. 2008. Metabolic, phylogenetic, and ecological 
diversity of the methanogenic Archaea. Ann N Y Acad Sci 1125:171-189. 
18. Lovley DR. 2018. The hydrogen economy of Methanosarcina barkeri: Life 
in the fast lane. J Bacteriol doi:10.1128/JB.00445-18. 
19. Lünsdorf H, Niedrig M, Fiebig K. 1991. Immunocytochemical localization 
of the coenzyme F420-reducing hydrogenase in Methanosarcina barkeri 
Fusaro. J Bacteriol 173:978-984. 
20. Meuer J, Bartoschek S, Koch J, Künkel A, Hedderich R. 1999. Purification 
and catalytic properties of Ech hydrogenase from Methanosarcina barkeri. 
Eur J Biochem 265:325-335. 
21. Meuer J, Kuettner HC, Zhang JK, Hedderich R, Metcalf WW. 2002. 
Genetic analysis of the archaeon Methanosarcina barkeri Fusaro reveals 
a central role for Ech hydrogenase and ferredoxin in methanogenesis and 
carbon fixation. Proc Natl Acad Sci U S A 99:5632-5637. 
22. Nayak DD, Metcalf WW. 2017. Cas9-mediated genome editing in the 
methanogenic archaeon Methanosarcina acetivorans. Proc Natl Acad Sci 
U S A 114:2976-2981. 
23. Paul K, Nonoh JO, Mikulski L, Brune A. 2012. "Methanoplasmatales," 
Thermoplasmatales-related archaea in termite guts and other 
environments, are the seventh order of methanogens. Appl Environ 
Microbiol 78:8245-53. 
 164 
24. Peters JW, Schut GJ, Boyd ES, Mulder DW, Shepard EM, Broderick JB, 
King PW, Adams MWW. 2015. [FeFe]- and [NiFe]-hydrogenase diversity, 
mechanism, and maturation. Biochim Biophys Acta 1853:1350-1369. 
25. Prasse D, Förstner KU, Jäger D, Backofen R, Schmitz RA. 2017. sRNA154 
a newly identified regulator of nitrogen fixation in Methanosarcina mazei 
strain Gö1. RNA Biol 14:1544-1558. 
26. Reichlen MJ, Vepachedu VR, Murakami KS, Ferry JG. 2012. MreA 
functions in the global regulation of methanogenic pathways in 
Methanosarcina acetivorans. mBio 3:e00189-12. 
27. Sawers RG, Pinske C. 2017. NiFe-hydrogenase assembly. In Scott RA 
(ed), Encyclopedia of Inorganic and Bioinorganic Chemistry 
doi:10.1002/9781119951438.eibc2484. 
28. Thauer RK, Hedderich R, Fischer R. 1993. Reactions and enzymes 
involved in methanogenesis from CO2 and H2, p 209-252. In Ferry JG (ed), 
Methanogenesis: Ecology, Physiology, Biochemistry & Genetics. 
Chapman & Hall, New York, NY. 
29. Thauer RK, Kaster A-K, Seedorf H, Buckel W, Hedderich R. 2008. 
Methanogenic archaea: ecologically relevant differences in energy 
conservation. Nat Rev Microbiol 6:579-591. 
30. Thauer RK, Kaster A-K, Goenrich M, Schick M, Hiromoto T, Shima S. 
2010. Hydrogenases from methanogenic archaea, nickel, a novel cofactor, 
and H2 storage. Annu Rev Biochem 79:507-536. 
31. Yan Z, Wang M, Ferry JG. 2017. A ferredoxin- and F420H2-dependent, 
electron-bifurcating, heterodisulfide reductase with homologs in the 
domains Bacteria and Archaea. mBio 8: e02285-16. 
 
